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ABSTRACT 
One means whereby the mammalian kidney excretes strong acid is by 
the formation of neutral ammonium salts in the urine. In response to 
a continuous acid challenge, the rate of ammonia excretion increases to 
meet the increased acid load. In the present study a strong acid load 
was administered to rats for 7 days, Ammonia excretion increased slowly 
reaching plateau levels after about three days. After the acid challenge 
was discontinued, the rats were placed back on tap water and allowed to 
recover. Ammonia excretion abruptly fell to normal within 24 hours. 
Phosphate dependent glutaminase (PDG) activity, the penetration of 
glutamine into mitochondria (the site of PDG) and phosphoenolpyruvate 
carboxykinase (PEPCK) activity have all been considered as rate-determining 
for the renal production of ammonia. For this reason the activities of 
PDG and PEPCK were measured in vitro during adaptation and recovery. 
Also glutamine metabolism (ammonia production and oxygen consumption) 
and the metabolism (oxygen consumption) of related substrates (glutamate, 
a-ketoglutarate and succinate) by isolated kidney cortex mitochondria 
were followed . In addition, glutamine metabolism (glutamine utilization, 
ammonia production, glutamate formation and glucose production) and the 
metabolism (glucose production) of related substrates (oxaloacetate, 
malate, lactate and pyruvate) by kidney cortex slices were measured during 
recovery. Mitochondrial capacity (PDG activity, oxygen consumption and 
ammonia production from glutamine) appears to correlate with the excretion 
of ammonia in the urine during adaptation. This correlation is consistent 
with ammonia production being regulated by a mitochondrial event. PEPCK 
attained maximum activity in vitro 24 hours before ammonia excretion 
(ii) 
reached its plateau. This suggests that the amount of PEPCK is not rate-
determining during adaptation. During recovery mitochondrial capacity 
remained at high plateau levels whereas the activity of PEPCK in vitro 
fell to normal values within 24 hours, The lack of a correlation between 
mitochondrial capacity and urine ammonia excretion suggests that renal 
ammonia production is not regulated solely by a mitochondrial event 
during recovery. No change in the mitochondrial metabolism of glutamate, 
a-ketoglutarate or succinate was observed during either adaptation or 
recovery. The remarkable correlation found during recovery between 
PEPCK activity in vitro, the metabolism of glutamine and related sub-
strates by kidney cortex slices, and urinary ammonia excretion is con-
sistent with PEPCK playing a regulatory role in ammonia production during 
this phase. Glutamine arteria-renal venous differences were also 
measured during adaptation and recovery and at all times paralleled the 
rate of ammonia excretion in the urine. Blood pH, [HCO)J, and pco2 
were followed to help assesstheir possible regulatory significance. No 
simple correlation appears to exist between any of these parameters and 
urinary ammonia excretion. 
Rats recovering from 7 days of acid challenge were also starved. 
During this starved recovery PEPCK decreased slightly but remained 
elevated, yet ammonia excretion returned to normal. This dissociation is 
not consistent with this enzyme alone being regulatory for ammonia pro-
duction. 
Rats were also returned to tap water after only 3 days of acid 
challenge. In comparison to recovery from 7 days of acid challenge 
urinary ammonia excretion persisted for an additional 24 hours. Since the 
(iii) 
acid~base status of the animal was shown to improve only afte~ ammonia 
excretion had been fully adapted ~or some t~me~ then the persistence of 
elevated ammonia excretion supports the idea that the excretton of am-
monia during recovery is related to restoration of acid-base balance. 
(iv) 
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INTRODUCTION 
Recently, Robert Pitts called attention to C~aude Bernard~s concept 
that '~we have achieved a free and independent life, mentally and phy-
sically by becoming relatively independent of our external environment" 
(84). Since the kidneys play a prominent role in the regulation of the 
composition of the internal environment, Pitts feels justified to claim 
"that our present high station in the animal kingdom ultimately depends 
on our kidneys" (84). 
A. Excretion of Acid 
One of the most precisely regulated components of the internal en-
vironment is the concentration of hydrogen ions. Under normal cir-
cumstances, the pH of blood plasma of mammals is maintained remarkably 
constant within the limits of 7.35 and 7.45, in spite of the many pro-
cesses occuring which might be expected to change it greatly. This 
precise regulation is necessary because of the highly reactive nature 
of hydrogen ions. Their small radius permits very strong interactions 
with negatively charged groups of macromolecules. Since the physiological 
activities of macromolecules depend upon charge and conformation, 
changes in the concentration of hydrogen ions will markedly affect their 
activities, and thus impair their biological roles. The minimum pH o.f blood 
which can be tolerated is generally stated to be 7.0. 
Hydrogen ions are derived from the daily ingestion of acid in the 
diet and from acids produced in the normal metabolism of foodstuffs and 
from the catabolism of body proteins and phospholipids. The stabilization 
of hydrogen ions is accomplished by the chemical buffering systems of the 
body. Some acids (lactic, S-hydroxybutyric and acetoacetic acids), 
under normal conditions, only transiently contribute hydrogen ions be-
cause they are metabolized further. Other acids (carbonic, sulfuric, 
hydrochloric and phosphoric acids) cannot be metabolized further and in 
order to prevent exhaustion of the chemical buffers, these acids must 
be eliminated from the body. Carbonic acid is in equilibrium with co2 
and H2o. The removal of co2 by the lungs effects the elimination of 
this acid. All other acids which cannot be metabolized further are 
transported, mainly as neutral sodium salts, from their source via 
the blood to the kidneys. 
In the span of 24 hours, acid production for normal man on a normal 
mixed diet is such that the kidneys are required to excrete about 40-80 
milliequivalents of hydrogen ions in the urine (83). The elimination 
of these hydrogen ions (Figure 1) involves the exchange of tubular sodium 
ions for hydrogen ions of the adjacent tubular cells (81). In this ex-
change, Na+ ions enter the tubular cells down an electrochemical gradient, 
which essentially drives the carrier-linked (72) secretion of H+ ions into 
the tubular lumen against an electrochemical gradient (68, 89). Although 
the favourable Na+ electrochemical gradient is maintained by the 
pumping of sodium ions from the tubular cells into the peritubular blood 
(83), the exchange mechanism can operate only up until a H+ ion concen-
tration gradient of about 800-1000 to 1 between the tubular lumen and the 
peritubular blood (81). This means that the kidney cannot form urine 
of pH less than about 4.4-4.8. 
~n the elimination of H+ ions, the exchange mechanism titrates the 
conjugate bases of the neutral sodium salts which were formed in the blood 
2 
TUBULAR FLUID 
Na+ 
X 
H+ 
L 
H 
NH + 
4 
X 
. RENAL TUBULAR CELL BLOOD 
+ Na+ Na 
H+ + HC03 HC03. 
"" . /H2C03 
. H20 + co 2 
--"~a Ketoglutarate 
Figure 1 Excretion of Acid 
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for their transportation to the kidney (Figure 1). The H+ ions, which 
are secreted into the tubular fluid, and the Reo; ions, which are re-
+ turned to the peritubular blood in association with Na ions, are derived 
from cellular carbonic acid. This H2co3 is. derived in part from co2 
produced in cellular metabolism and in part from co2 brought to the cell 
in peritubular blood. The amount of free acid which can be formed without 
achieving a limiting pH gradient depends upon the pK of the acid. If the 
pK is high, in comparison to the pH of the urine, then a relatively 
large amount of 11+ ions can be excreted as the free form of the acid. If 
the pK is low, then the acid being formed will largely be dissociated 
and the H+ ions may easily accumulate so as to prevent continued ex-
change. 
+ In normal man some 10 to 30 mEq of the total 40 to 80 mEq of H ions 
excreted each day are excreted as free or titratable acid (83). The 
major fraction of this titratable acid is dihydrogen phosphate. The 
pK of this acid is 6. 8 and therefore the monohydrog·en form of the acid 
presented to the kidney is largely titrated to the dihydrogen form without 
appreciably lowering the urinary pH. The remaining 30-50 mEq of H+ ions 
cannot be excreted as titratable acid because the pKs of the acids that 
would be formed are very low and the necessary fall in urinary pH would 
prevent continued secretion of H+ ions. 
Ammonia plays a unique role in overcoming this potential limitation 
in the excretion of stronger acids. Its importance is dependent on the 
fact that ammonia is both a gas and a base. By virtue of its gaseous 
nature~ small size and lipid solubility~ ammonia can rapidly diffuse from 
the renal tubular cells, its site of production, into the tubular lumen. 
5 
By virtue of its basicity, ammonia can bind hydrogen ions in the tubular 
fluid to form ammonium ions. A pK of 9.2 ~ 9.3 for ammonia means that 
at urinary pH the formation of ammonium ions is greatly favoured. Am-
monium ions are not lipid~soluble and as a result a re essentially trapped 
in the tubular fluid. 
The diffusion of ammonia into the acid urine and the formation of 
impermeant ammonium ions~ th.erefore, prevents the a c cumulation of tubular 
H+ ions and allows for the excretion of strong acids as neutral am-
monium salts. The conversion of ammonia to ammonium tends to lower the 
pNH3 of the tubular fluid and thus favours continued ammonia diffusion. 
This mechanism therefore allows for the continued e x change of Na+ ions 
for H+ ions, effecting the elimination of H+ ions from the body and the 
replenishment of blood buffer. 
B. Production of Ammonia 
1. Metabolic Pathways 
In the mammalian kidney, ammonia is produced in the renal tubular 
cells along the entire length of the nephron (83). The principal source 
of this urinary ammonia in man (76), dog (85) and rat (106) is glutamine. 
Glutamine is supplied to the kidney in the arterial blood and enters the 
tubular cells, from the filtered fluid, across the luminal surface and, 
from the peritubular blood, across the antiluminal surface (101). 
Theoretically, there are several enzymes in the renal tubular cells 
capable of releasing ammonia from glutamine. However, only the enzymes 
of two pathways have been extensively considered as important in the 
production of ammonia. 
6 . 
The first pathway (glutaminase I pathway) invclves the sequential 
action of phosphate dependent glutaminase and glutamate dehydrogenase: 
glutamine 
NH3 HzO ~H) 
H20 (PDG) 2 - ~H) f 
'-- ~ ) glutamate ~<--r,----?-----~---7) a-ketoglutarate 
W NAD+ ( · H + W) + H+ 
2-
Phosphate dependent glutaminase, so-called becaus·e its in vitro activity 
depends upon phosphate, removes the amide-N of glu~amine as ammonia. 
Glutamate dehydrogenase then releases the remaining amino-N as ammonia 
by converting glutamate to a-ketoglutarate. The enzymes of the glutaminase 
I pathway are located inside the mitochondrial inrner membrane (20, 56). 
Therefore, in order for glutamine to become available for ammonia 
synthesis, via this pathway, it must be transported across the inner 
mitochondrial membrane. 
The second pathway (glutaminase II pathway) consists of two linked 
reactions, catalyzed by glutamine transaminase and w-amidase. Glutamine 
transaminase catalyzes the transamination of glutamine with an a-keto 
receptor to yield a-ketoglutaramate. Although this reaction does not 
release ammonia, it forms an amino acid from an ~-keto acid. The amino 
acid can then be transaminated, with a-ketoglutarate by ubiquitous 
transaminases, to form glutamate, the substrate f~r glutamate dehydrogenase: 
7 
a-keto(d ~amino acid HzO NH
3 
+ H + 
2 glutamine <(,: a.-ketoglutaramate- \ 1) a-ketoglutarate -
(G. T.) H+ (w-amidase) 
w-amidase releases the amide-N of glutamine as ammonia by converting a.-
ketoglutaramate to a.-ketoglutarate. 
Although both pathways are found in all mammalian kidneys examined 
(94), various in vitro estimates of their activities indicate the 
glutaminase I pathway to be predominant (7, 33, 93). A similar con-
elusion is drawn from studies using intact rat kidney cortex slices. 
Relman and Narins (93) have shown that an inhibitor of glutamine 
transaminase does not have any significant effect on the production of 
ammonia by these slices, whereas Goldstein (31) found that an inhibitor 
of glutaminase resulted in a marked reduction in ammonia production. 
Welbourne (112) has also promoted y-glutamyl transferase as a possible 
source of renal ammonia but the physiological significance of this path-
way is obscure. 
2~ Removal of Carbon Skeleton 
At physiological pH glutamine is a neutral substance, whereas a.-
ketoglutaric acid is a strong dibasic acid. Consequently, the production 
of ammonia, via the glutaminase I pathway, results in the formation of 
8 
2 protons. In order for the arnmonias to become available to buffer 
urinary acid, a~ketoglutarate must be concomitantlymetabolized to a 
neutral substance in a manner that utilizes the protons. One means of 
accomplishing this is conversion of a-ketoglutarate to glucose. This 
re~uires that the carbon skeleton leave the mitochondrion and that NADH 
be generated in the cytosol for reversal of the triosephosphate de-
hydrogenase step during gluconeogenesis. Both of these requirements are 
met if the carbon skeleton leaves the mitochondrion as malate and is 
then oxidized to oxaloacetate via malate dehydrogenase. Another means 
of removing a~ketoglutarate is by complete oxidation to co2 and H2o. In 
this case, the carbon skeleton of a-ketoglutarate must leave the Krebs 
cycle by a route which converts it to pyruvate so that it may re-enter 
the cycle as acetyl CoA. Pitts (82) and Goodman (39) have suggested that 
this might occur by conversion of oxaloacetate to pyruvate via the 
cytosolic enzymes phosphoenolpyruvate carboxykinase and pyruvate kinase. 
It appears, however, that oxaloacetate is not able to translocate from 
the mitochondrial matrix into the cytosol (44). Lardy and co-workers (67) 
have proposed that other metabolites serve as transport derivatives for 
oxaloacetate. Their evidence suggests that in a situation like this, 
where no cytosolic NADH is required, oxaloacetate is transaminated to 
aspartate which then passes into the cytosol and regenerates oxalo-
acetate by the converse reaction. 
C. Regulation of Ammonia Production 
1. Adaptation 
In abnormal states (starvation, diabetes, ingestion of strong acids) 
9 
when more than normal amounts of H+ ions must be eliminated, the kidney 
has the ability to increase the rate of excretion of H+ ions up to 
about 10 times that of their normal rate. In part, this is due to the 
ability of the kidney to increase the amount of free acid in the urine 
up to the pH of maximal acidity, about 4.6. However~ the acids requiring 
elimination in these abnormal states are usually relatively strong acids 
of low pK (for example, hydrochloric, B-hydroxybutyric, acetoacetic and 
sulfuric acids) and the device of acidifying the urine is not effective 
for eliminating these H+ ions. ~fuat is important is the ability of the 
kidney to increase the rate of ammonia excreted. Apparently, the rate 
of ammonia excretion depends upon 2 factors (80): (1) urine pH and 
(2) cellular production. The adaptive increase in ammonia excretion is 
a slow process, taking place over several days. Urine pH in the 
chronically adapted stage is essentially the same as that in the acute 
stage, yet it is during this period of adaptation that the greatest in-
creases in ammonia excretion are observed (80). Fur~hermore, Pitts 
has shown that the rate of ammonia excretion by the chronically adapted 
kidney is considerably greater at any given urinary pH value than that 
by the normal kidney (80). These observations are interpreted as meaning 
that the major determinant of ammonia excretion is c€llular production. 
2. Regulation 
It is apparent that in order for the adaptive changes which occur in 
the production of ammonia to take place, the flux through the pathway and 
hence the activities of all the steps in the metabo1ism of glutamine must 
increase. In this sense, the activities of all the steps in the pathway 
10 
are "regulated". The crucial and yet unanswered quest ions are~ 
(1) which step in the sequence responds to the initial signal and 
thereby effects changes in the other steps. 
(2) what is the original signal which triggers these changes. 
It seems certain that availability of glutamine in the blood is 
not a rate-determining factor for the increase in ammonia production since 
the quantity of glutamine delivered to the kidneys in the arterial blood 
does not differ significantly in acidosis and alkalos is (2~ 101~ 106). 
Neither can increased transport of glutamine across the luminal surface 
be invoked~ as essentially the same quantities are filtered and reabsorbed 
in acidosis and alkalosis~ yet far greater quantities are utilized in 
acidosis (79). It therefore seems likely that the production of ammonia 
is regulated by an intracellular step in the metabolism of glutamine. 
3. Hypotheses 
At present there are three principal hypotheses regarding the identity 
~the regulatory step in the renal metabolism of glutamine: 
(a) Transport hypothesis. One hypothesis~ suggested by Pitts (83) 
proposes that the site of regulation of ammonia production is the trans-
port of glutamine across the inner mitochondrial membrane. Although there 
is no irrefutable evidence for a specific carrier-mediated transport 
system for glutamine~ the demonstration of other transport systems (62) 
involved in the regulation of mitochondrial metabolism lends credibility 
to this hypothesis. One of the major problems in studying this process~ 
from the viewpoint of regulation~ is that it is difficult, with the 
presently used techniques (62), to measure initial rates of entry of 
11 
glutamine into mitochondria. However~ Crompton anro Chappell (18) claim 
to have measured the initial rate of entry of glutanine into pig renal-
cortex mitochondria. Their calculations reveal that the rate of glutaminE· 
entry into isolated mitochondria is considerably sl~ver than the rate at 
which glutamine is deamidated by disrupted mitocho~ria. This is taken 
to suggest (33) that the transport of glutamine ac~ss the inner mito-
chondrial membrane is rate-limiting for the deamidattion of glutamine. 
The studies of Adam and Simpson (1) also suppo~ this hypothesis. 
In their experiments they were unable to demonstrate the accumulation of 
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c-glutamine in the mitochondrial matrix, when mibnchondria, isolated 
from rat kidney cortex, were incubated with as much as 10 mM 14c-glutamine 
and then rapidly centrifuged through silicone into ~rchloric acid. This 
suggests that the transport of glutamine across the inner mitochondrial 
membrane is slower than its subsequent deamidation ~nside the matrix. The 
same result was obtained using dog kidney cortex m±tochondria (104). At 
variance with these results, Crompton and Chappell ( 18) found labelled 
glutamine inside the matrix space of pig kidney mitnchondria when in-
b d · h 14c 1 · · d.ff d. cu ate w1t -g utamlne 1n a 1 erent me 1um. llibwever, Adam and 
Simpson, using a medium identical to that described by these authors, 
were still unable to demonstrate glutamine in the ~trix space of either 
rat kidney mitochondria (1) or pig kidney mitochondr ia (104). In ex-
periments using inhibitors of glutamine deamidation (low temperature, p-
chloromercuribenzoate~ mersalyl) glutamine was still not detectable inside 
the matrix space in either rat kidney mitochondria ( 1) or dog kidney 
mitochondria (104). It therefore appears that even at these reduced rates 
of deamidation~ the transport step is still slower .~d, therefore, rate-
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limiting. It is possible, however, that these inhibitors also affect 
glutamine transport, in which case, the inability to detect glutamine 
inside the matrix space under these circumstances cannot be taken as 
evidence for the idea that transport is rate~limiting. It is also 
possible that the transport process and deamidation are closely linked 
so that only glutamate is released into the matrix space. In such an in-
stance, the regulation of the overall transport deamidation complex, 
rather than transport per se, would be important. 
Other support for the transport hypothesis comes from what appears 
to be an increase in the uptake of 14c-glutamine by kidney cortex mito-
condria isolated from rat (1, 32) and dog (104) after these animals had 
received an acid load. These increases are based upon increases in the 
d · f · 1 b 1 f · b · · h 14c stea y-state concentrat1ons o matr1x a e a ter 1ncu at1on w1t -
1 · Th 1 · f · 14c · · 1 · h f f 14c g utam1ne. e accumu at1on o matr1x 1s ma1n y 1n t e arm o -
glutamate since metabolic inhibitors (rotenone, arsenite) were added to 
the medium to prevent conversion of glutamate to other products. The in-
ference that an increase in the steady-state concentration of glutamate 
reflects an increase in glutamine transport assumes no alteration in the 
rate and affinity of the glutamate exit system. These may be hazardous 
assumptions. 14 Accumulation of C-glutamate could also be caused by 
either a decreased exit of glutamate from the mitochondria or a de-
creased affinity of the glutamate exit mechanism. Adam and Simpson (1) 
14 have already shown that the uptake of C-glutamate is quite depressed 
in mitochondria isolated from rats given an acid load and hence the 
activity of the glutamate transport mechanism may be lowered. Goldstein 
(32) has also studied mitochondrial transport using 6-diazo-5-oxo-L-
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norleucine (DON), an analogue of glutamine. This analogue is apparently 
transported by the system that transports glutamine across the inner 
mitochondrial membrane but is not hydrolyzed by rat renal glutaminase. 
He found a 1.5 - 2.0 fold increase in the steady-state accumulation 
of this analogue despite the fact that such accumulations cannot be due 
to either increased glutaminase activity or to an involvement of the 
glutamate transporter. However, Goldstein did not measure the initial 
rate of entry and it must be emphasized that an increased steady-state 
accumulation of DON does not necessarily imply an increased rate of 
entry. Again alterations in the rate and affinity of DON effux may be 
responsible. 
The increase in 14c-glutamate accumulation by dog kidney cortex 
mitochondria incubated with 14c-glutamine is consistent with the idea 
that a carrier system is involved in the regulation of ammonia production, 
since in this species there is no observable increase in the activity of 
PDG in vitro (104). Also, there was an increase in accumulation of 
label by rat renal cortex mitochondria incubated with 14c-glutamine 
after only 3 hours of acid challenge, without a concomitant increase in 
extractable PDG activity (1). However, in contrast, Goldstein (32) did 
not find an increase in the steady-state accumulation of 14c-glutamate 
by rat kidney cortex mitochondria incubated with 14c-glutamine after 2 
days of acid challenge, even though ammonia excretion in vivo was 
significantly increased. 
(b) ·Phosphate dependent glutaminase hypothesis. A second hypothesis pro-
poses that the deamidation of glutamine by phosphate dependent glutaminase is 
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the regulatory step in the renal production of ammonia. This hypothesis 
was originally postulated by Pitts, who suggested (80) that the ex~ 
cretion of ammonia was regulated by ch~nges in the concentration or amount 
of glutaminase within the renal tubular cells. The plausability of this 
suggestion was strengthened by Davies and Yudkin (22). These workers 
demonstrated that kidney cortex slices taken from rats given an acid 
load produced considerably more ammonia from glutamine than slices taken 
from normal animals. Subsequently, it was shown that the activity of PDG 
increased in the kidney of the rat (6, 68, 87, 91, 92, 109) and the 
guinea pig (35, 36, 94) in response to an acid challenge. After the first 
24 hours of acid challenge, enzyme activity and urinary ammonia excretion 
correlate well in both the rat (92) and the guinea pig (35). The lack 
of a measurable increase in PDG activity (6, 68, 92) during the earlier 
stage of acid challenge (i.e., up to 24 hours), despite increases in 
ammonia excretion (68, 92) suggests that changes in the amount of enzyme 
cannot be the sole means whereby the synthesis of ammonia is regulated. 
However, it may be, as demonstrated by Curthoys and Lowry (19), that 
since the kidney is such a heterogenous system, studies with the whole 
organ must tend to average out or partially mask the magnitude of 
adaptive responses in a small portion of the nephron. These workers 
showed, by microanalytical techniques, that the 2-4 fold increase ob-
served in whole kidney homogenates is in reality caused by a 20-fold 
increase within the proximal convoluted tubules (19). Thus, it is 
certainly possible that changes in PDG activity do occur during the first 
24 hours of acid challenge but are not detectable in whole kidney homo-
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genates. In fact, alterations in the activity in the proximal con-
voluted tubules must occur before they are manifest in the whole 
homogenate. 
Mo~e serious doubt is cast upon this hypothesis by other anomalous 
findings. The activity of PDG in canine kidney does not change during 
acid challenge despite large increases in ammonia production (87, 91). 
Although this finding, in itself, does not discount the validity of the 
hypothesis for other species, it does at least demonstrate that this 
hypothesis is not universally applicable. Evidence against this 
hypothesis for the rat comes from work by Goldstein (29) and Bignal et 
al. (11), who both found a small increase in PDG activity after 1 day of 
acid challenge. Goldstein's experiments showed that an antibiotic, 
actinomycin D, inhibited the adaptive rise in PDG activity, but failed 
to inhibit the increase in ammonia excretion. The experiments of Bignal 
et al. (11) also show (75), using actinomycin D, that an adaptive 
increase in ammonia excretion can occur in the rat without a change in 
enzyme activity. However, actinomycin D is very toxic and cannot be ad-
ministered for periods longer than 24 hours. Therefore, these experiments 
using actinomycin D can only be taken as evidence against this hypothesis 
for the first day of acid challenge. It is still possible that ammonia 
production is regulated by changes in the amount of PDG after this period. 
A similar study (74) in the rat, using ethionine as an inhibitor of pro-
tein synthesis (amino acid anologue), failed to inhibit the adaptive rise 
in ammonia excretion. However, although ethionine has been shown to 
inhib~t the adaptive increase in renal PDG activity in the guinea pig (35), 
it was found to be only partially effective in producing complete in~ 
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hibition of PDG induction in the rat (37). 
(c) Phosphoenolpyruvate carboxykinase (gluconeogenesis) hypothesis. 
A third hypothesis proposes that the regulatory step in the renal pro-
duct~on of ammonia is that catalyzed by phosphoenolpyruvate carboxy-
kinase (PEPCK). This enzyme is required for conversion of oxaloacetate 
(OAA) to phosphoenolpyruvate (PEP) and is almost entirely cytoplasmic in 
the rat (27). According to th~s hypothesis, changes in the activity of 
PEPCK regulate the removal of the carbon skeleton of glutamine to 
glucose, thereby regulating the level of glutamate inside the mito-
chondrion, which in turn controls the activity of PDG by-product in-
hibition. This hypothesis is based upon the. observations that glutamate 
is an effective inhibitor of rat renal PDG at concentrations normally 
found in the kidney (30, 37, 38) and that glutamate concentration in the 
kidney decreases (21, 30, 34, 37, 38) when the rat is given an acid 
load. The findings that an acid challenge also stimulated gluconeo-
genesis in rat kidney cortex slices (4, 17, 41, 42, 59) and that glucose 
production was a major fate of glutamine in the rat kidney (57, 59) lead 
to the proposal that changes in glutamate concentration was regulated 
by gluconeogenesis. This idea was further strengthened by the de-
monstration of a positive correlation between the adaptive increases in 
ammoniagenesis and gluconeogenesis in kidney cortex slices taken from 
rats given an acid load for at least 48 hours (4, ~7, 42, 57, 59). 
Subsequently, it was shown that the conversion of OAA to PEP was enhanced 
(3) and that the adaptive increase in renal PEPCK activity directly 
correlated with urinary output of ammonia (6). 
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One di~ticulty in accepting this hypothesis is that the concentration 
of glutamate inside the ~itochondrion is controlled by the activity of 
an enzyme (PEPCK) in the cytosol and that for changes to occur in 
glutamate levels, this enzyme must exert a "pull" across the inner mito-
condrial membrane and through all the intervening reactions. This 
necessitates that all the intervening steps be poised quite close to 
equilibrium, which has never been demonstrated and appears most unlikely. 
Apart from this theoretical objection, other more demonstratable 
findings are inconsistent with this hypothesis. One such criticism is 
that the drop in renal cortical glutamate is not of sufficient magnitude 
to account for the adaptive increase in urine ammonia excretion and 
that increases in ammonia excretion during prolonged acid challenge occur 
without corresponding decreases in glutamate concentration (30, 38). 
Furthermore, administration of an acid load to rats in an amount inadequate 
to decrease cortical [glutamate] increased the capacity of cortex to 
produce ammonia from glutamine (77). However, in defense of this 
hypothesis, it may be that changes in the concentration of glutamate within 
the cortical mitochondrial compartment, in which PDG is located, are not 
reflected in total glutamate concentrations. On the other hand, Adam 
and Simpson (1) reported that the glutamate content of mitochondria isolated 
from rats given an acid load was higher, not lower, than that of mito-
chondria isolated from control rats. Another criticism of this hypothesis 
is the lack of a correlation between glucose and ammonia production in 
rat kidney cortex slices during the early stage of acid challenge (i.e., 
up to 6 hours) (4). This is somewhat disturbing, since it may indicate 
that the two processes are not directly linked and that increased 
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gluconeogenesis is a consequence rather than a cause of increased ammonia 
production. 
Studies using Krebs cycle inhibitors also show a dissociation between 
ammoniagenesis and gluconeogenesis. Churchill and Malvin (17) inhibited 
gluconeogenesis from glutamine in rat kidney cortex slices with either 
malonate or phenylpyruvate without affecting ammoniagenesis (malonate) or 
stimulating it (phenylpyruvate). Preuss (88) found that the addition of 
malonate or arsenite to the incubation medium failed to block the in-
creased ammonia production seen in rat renal cortical slices, when the 
medium pH was decreased. However, glucose production was almost completely 
abolished. Kamm and Asher (57) however, argue against the validity of 
these studies. They point out the possibility that products other than 
glucose may accumulate and these were not measured. Recently Bennett and 
Alleyne (9) used what is thought to be a more specific inhibitor, mercap-
topicolinic acid, to inhibit PEPCK. Their results show that the de-
crease in glucose production coincides with a decrease in ammonia pro-
duction, suggesting that the two processes may indeed by causally linked. 
Iynedjian et al. (53) showed, using isotopic-immune chemical pro-
cedures, that the adaptive increase in rat renal PEPCK activity is due to 
an increase in the synthesis of new enzyme. These workers also found that 
the increase in activity could be prevented by actinomycin D at doses much 
higher than those used by previous workers (27, 69), who failed to find 
inhibition. Since inhibition of PDG induction occured at doses which 
were found not to inhibit PEPCK induction (11, 29), it is not known 
at present whether the adaptive increase in PEPCK activity is necessary 
for the adaptive increase in ammonia excretion. 
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Glutamate has also been shown tq be an e~fective inhibitor of dog 
renal PDG (8, 98) and its concentration in the dog kidney cortex also 
decreases when an acid load is administered to the animal (101, 107). 
The activity of PEPCK is known to increase under these circumstances (103). 
Thus, the PEPCK (gluconeogenesis) hypothesis has also been considered for 
the dog. However, the relationship between ammoniagenesis and gluconeo-
genesis is even more tenuous than in the rat. The studies of Malvin and 
Churchill (16) and Roxe et al. (97) did not detect a significant change 
in renal glucose output in vivo in dogs to which an acid load had been 
administered. However, this is not surprising since the blood flow of 
the kidney is so high that even if all the glutamine extracted was con-
verted to glucose the resultant increase in renal venous glucose would 
be exceedingly small. Steiner et al. (107), using a more precise method 
for measuring blood glucose, found a very small but statistically 
significant increase in renal glucose output in vivo in dogs given an acid 
load. This increase in renal glucose output was in the range which would 
be expected if much or all of the glutamine giving rise to augmented 
ammonia production was ultimately converted to glucose. However, the in-
crease in glucose production, although significant, was so small that this 
study cannot be taken as conclusive proof that renal gluconeogenesis is 
enhanced (39). In addition, glucose A-V differences are difficult to in-
terpret because the medulla is a potentially important user of glucose 
(71). Therefore, an increase in glucose output by the kidney may also be 
interpreted as a decrease in glucose utilization by the medulla. 
A correlation between the adaptive increases in glucose and ammonia 
production by dog kidney cortex slices has only been demonstrated (15) 
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~reduced medium pH (j.e., 7.0), Even then~ cortex slices from dogs pro-
duce much less ammonia and glucose than slices from rats when comparable 
concentrations of glutamine are used as substrate (15). Most evidence (78, 
82, 86) indicates that in the dog, unlike the rat, renal gluconeogenesis 
is a minor pathway for disposal of the glutamine carbon skeleton. However, 
PEPCK is probably also involved in the total oxidation of glutamine to 
co2 • Therefore, this enzyme may also be of importance in ammonia pro-
duction in the dog. 
Yu et al. (116), in a recent study, observed that infusion of neutral 
sodium phosphate elicited a large increase in ammonia excretion by the 
acidotic rabbit. A similar effect coul d be observed ~ vitro (slices and 
isolated mitochondria) and in the case of mitochondria the effect was 
shown to involve the malate/phosphate antiporter. The exit of malate 
(the possible end product of mitochondrial metabolism) from the mito-
chondrion occurs via the malate/phosphate antiporter and is stimulated 
by elevated concentrations of extramitochondrial phosphate. This study 
directs attention to the role of mitochondrial transporters other than 
the glutamine transporter. Additionally, it shows that the three pos-
sibilities for regulation of ammonia production discussed above (i.e., 
PDG, glutamine transport and PEPCK-gluconeogenesis) are not the only 
ways in which control has been envisaged. 
4. Metabobolic Signals 
Although the nature of the metabolic signals involved in the 
regulation of ammonia production cannot be identified with certainty 
until the rate-determining step has been positively identified, a number 
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of possible candidates exist. One of the most obvious and pr~mary ef-
fects of an acid challenge is a drop in olood pH~ Such a drop in pH 
could be a signal for indirectly or directly activating ammonia production 
by the renal tubular cells. It is possible it may indirectly act by 
altering the plasma concentration of glucose precursors, such that 
glutamine is preferentially used, It is also possible that a drop in 
blood pH may effect the release of an extrarenal hormone. The involvement 
of a hormone was suggested by studies of Alleyne and Roobol (5). 
These workers demonstrated a dialyzable factor, present in the plasma 
of acutely acidotic rats, which increased the ammonia production of 
normal kidney cortex slices when added to the incubation medium. A 
change in systemic pH may also directly cause an alteration in the intra-
cellular pH of the cells responsible for renal ammonia production. 
Evidence for a direct role of pH is conflicting. Anm1onia production from 
endogenous substrates was shown to be increased when the pH of the 
medium bathing rat kidney cortex slices was decreased (48, 50, 95). 
Endogenous ammonia production by dog kidney cortex slices was shown either 
to be not affected (48) or to be increased (95) when the medium pH was 
lowered. When glutamine was added as substrate, lowering the medium pH 
either did not affect (52) or significantly decreased (40, 48, 93) ammonia 
production by rat kidney cortex slices, while ammonia production by dog 
kidney cortex slices was both increased (15, 78) and decreased (48). 
When glutamate was employed, ammonia production by rat kidney cortex 
slices was increased (88, 93) after the medium pH was lowered. Relman 
and Narins (73, 93) surmize, on the basis of the di{ference between 
ammoniagenesis from glutamine and glutamate by kidney cortex slices, that 
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lowering medium pH inhibits PDG> but enhances either the mitochondrial 
e£flux of malate (63) or the activity of ?EPCK. The relevance of this 
effect to the in vivo situa_tion remains to be determined. 
The effect of pH on the subsequent metabolism of glutamine is even 
more confusing. Glucose production by rat kidney cortex slices, using 
glutamine as substrate, is either not affected (5) or increased (52, 
58) by acidifying the medium. Glucose production from glutamate was 
shown to be increased (58, 88). Decreasing medium pH increased 
glucose production from glutamine (15, 78) by dog kidney cortex slices. 
co2 production from both glutamine and glutamate by rat renal cortex 
tubules was shown not be to affected (64, 65) by lowering medium pH, 
while co2 production by isolated rat kidney cortex mitochondria was 
inhibited (64, 65). On the other hand, co2 production from glutamine 
by dog kidney cortex slices and mitochondria were both shown to be in-
creased on acidifying the medium (105). The difference in the effect of 
lowered medium pH on co2 production, between the dog and the rat, is 
explained by Kurokawa and Rasmussen (65) as being due to differences in 
++-the Ca ion concentrations used. These same authors conclude from 
studying the metabolism of a number of different substrates by rat kidney 
cortex mitochondria and tubules (65, 105), that changes in H+ ion concen-
trations influence primarily intramitochondrial processes. 
The effect of pH on renal glutamine metabolism remains unclear, 
especially since most of the studies are performed using a bicarbonate 
buffer system, designated to resemble physiological conditions. A bi-
carbonate buffer consists of 3 variables: pH, Hco; and pC02 • It is not 
possible to maintain two of these variables constant while studying the 
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effect of the third. co2 production from glutamine by rat kidney cortex 
mitochondria (65) and dog kidney cortex mitochondria (105) was also in-
creased when [Reo;] and pC02 were lowered and pH kept constant, Cade 
et al. (14) found a good correlation between plasma pC02 and urine 
ammonia excretion in the acidotic dog. Kamm et al. (60) have shown that 
a positive correlation exists between total plasma co2 content (plus 
bicarbonate) and the activity of renal PEPCK in the rat. However, the 
increase in co2 production, observed by lowering [Reo;] and pC02 , at 
constant pH, is not as great as that which occurs when pH is lowered 
(65, 105). Also, the relevance of bicarbonate to ammonia excretion is 
unclear, since adaptive increases in ammonia excretion are observed at 
low plasma bicarbonate (90) as well as at high plasma bicarbonate (51, 
99) and at normal plasma bicarbonate (92). 
The changes which occur in blood pH, [Reo;] and pco2 in relation to 
ammonia excretion during continuous acid challenge have not, as yet, 
been well investigated. Denning et al. (24) found that when an acid 
load was administered to humans for 14 days, the pH of the blood, after 
initially dropping, gradually returned to normal. Hilton administered 
an acid load for 30 days (47). He observed that acidosis developed and 
thereafter subsided, so that, after 4 weeks the plasma pH and [Hco;] 
had returned to normal, despite continued administration of acid . Wood 
(115) has described the effects of giving a daily acid load to a human 
subject for 44 days. He states that at no time during the experiment did 
plasma pH or [Hco;J return to normal. However, it is quite apparent from 
his results that after reaching minimum values~ after 3~4 days, these 
parameters then gradually returned towards normal. Plasma pC02 also re-
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turned towards normal after a drop during the first 3 days. Ammonia 
excretion, on the other hand, remained elevated after reaching a maximum 
at about 5 or 6 days& After the acid load was discontinued, plasma pH 
and [Reo;] rose above normal and then gradually fell, returning to 
normal after about 10 days. Plasma pC02 had returned to normal values 
after 3 or 4 days. Clearly, these results do not reveal any simple cor-
relation between any of these possible regulatory parameters (i.e., pH, 
[Reo;], pco2 ) and ammonia excretion. 
D. Purpose and Approach of this Study 
Despite the widespread interest in the control of renal ammonia-
genesis over the past 25 years, abundant enthusiasm has not yet been 
matched by corresponding progress in understanding the specific control 
mechanisms involved. Pitts recently remarked (83) that "no presently 
proposed theory of control of ammonia production is intellectually 
satisfying". 
As can be gathered from the foregoing introduction, all of the 
hypotheses are based mainly on correlative studies of events which take 
place during adaptation to an acid challenge. A correlation between 
two events does not necessarily mean that they are causally related. 
On the other hand, a dissociation or lack of correlation can be taken as 
evidence that two events are not causally related. However, most of the 
dissociations taken as evidence against the presently discussed hypotheses, 
occur in unphysiological situations or where the methods of detecting 
changes are subject to question~ 
Dies and Lotspeich (25) observed that, when rats were returned to 
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tap water after 5 days of ac~d challenge 1 the ammonia excretion abruptly 
fell to no~al values within 24 hours~ It therefore seemed possible 
that this phase of adaptation might be rewarding in either establishing 
dissociat~ons or confirming correlations. It was anticipated that the 
return of ammonia excretion to normal would be accompanied by a return 
to normal values of regulatory parameters 1 but not necessarily by a re-
turn to normal values of non-regulatory parameters. This search for 
such relationships was carried out at different levels of organization; 
i.e., from the level of enzyme activities through isolated organelle 
function and slice metabolism to the whole animal. Although studying the 
recovery phase was the original impetus for this work, changes which 
occur during acid challenge were also investigated in an attempt to 
fill in some of the gaps presently found in the literature. 
Materials 
A. Animals 
MATERIALS AND METHODS 
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Male Sprague-Dawley rats, weighing 250-500 g, were used in all ex-
periments. These animals were obtained from Canadian Farms and 
Laboratories Ltd., St. Constant, La Prairie, Quebec. They were fed a 
commercial Purina Rat Chow (Ralston Purina of Canad a Ltd., Don Mills, 
Ontario) which consisted of a minimum 22.0% protein, a minimum 4.0% fat 
and a maximum 5% fibre. The remainder of the rat chow was mainly 
carbohydrate plus mineral and vitamin supplements. 
B. Cofactors and Nucleotides 
NAD, NADH, ADP, ATP and ITP were obtained, as sodium salts, from 
Sigma Chemical Company, St. Louis, Missouri. 
C. Enzymes 
The following enzymes were purchased from Sigma Chemical Company: 
lactic dehydrogenase (type II), glutamic dehydrogenase (type II), 
pyruvate kinase (type II), hexokinase (type C-300) and PGO enzymes. 
D. Other Biochemicals 
Heparin (1000 units/ml) was obtained from M.T.C. Pharmaceuticals, 
Hamilton, Ontario. All other biochemicals were purchased from Sigma 
Chemical Company, St. Louis, Missouri, and were of the highest purity 
available. 
E. Other Chemicals 
"Somnotol", sodium pentobarbital (65 mg/ml), was obtained from M.T.C. 
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Pharmaceuticals. "~iliclad" (silicone) was obtained from Clay Adams, 
Parsippancy, New Jersey. Cesium chloride (biological grade) was 
purchased from Schwarz-Mann, Orangeburg, New York. Cation exchange 
resin (AG 50W-X8, 50-100 mesh) was purchased from Bio Rad Laboratories, 
Richmond, California. Phenol was obtained from BDH Chemicals, 
Toronto, Ontario. Commercial bleach (Javex), a source of sodium hypo-
chlorite, was obtained from Bristol-Meyers Canada Ltd., Toronto, 
Ontario . Water was treated by the Culligan Reverse Osmosis System, RDS 
1. All other chemicals were obtained from Sigma Chemical Company, St. 
Louis, Missouri; BDH Laboratory Chemicals Ltd., Poole, England; 
Fisher Scientific Company, Fawn La\vn, New Jersey or J.T . Baker Chemical 
Company, Phillipsburg, New Jersey and were of analytical grade purity . 
Methods 
A. Treatment of Animals 
On arrival, the animals were placed in standard rat cages (not 
more than 3 rats to a cage) containing hardwood bedding chips. The 
animals were allowed free access to food and water for a minimum of 2 
days. This period allowed them to adjust to their new environment. The 
animal room was continually lighted and maintained at constant tem-
perature . 
At the end of this period the animals were apportioned to either 
a control group or an experimental group. The control group was allowed 
free access to tap water and, depending on the experiment, either fed 
ad libitum until used or deprived of food for a period of up to 2 days. 
The treatment of the experimental group depended on the nature of the 
• 
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experiment. When adaptation to acid challenge was being examined, the 
animals were given free access to 1.5% (w/v) NH4Cl, in place of tap 
water, and fed ad libitum for periods of up to 7 days. When recovery 
from acid challenge was being examined, rats were given free access to 
1.5% (w/v) NH4Cl for either 3 days or 7 days. Animals which had been 
drinking 1.5% (w/v) NH4Cl for 3 days were returned to tap water for 
another 3 days. Animals which had been drinking 1.5% (w/v) NH4Cl for 7 
days were either returned to tap water for up to 2 days, or, in some 
experiments, returned to tap water and deprived of food for up to 2 days. 
B. Use of Metabolic Cages 
The use of metabolic cages entails certain errors. For the 
measurement of urinary ammonia excretion the principal potential errors 
are probably: 
(1) spillage of 1.5% (w/v) NH4Cl solution into the urine. 
(2) spillage of food and feces into the urine. 
(3) evaporation of urine on the collecting funnel. 
(4) evaporation of collected urine. 
(5) bacterial degradation of urea or other nitrogenous substances 
in the urine to yield ammonia. 
Measures were taken to minimize some of these errors. Also in 
some cases, the extent of the errors were estimated . 
(1) Spillage 
The rats used in these experiments drank between 15 and 34 m1* of 
fluid (1.5 % (w/v) NH4Cl) each day. The rat metabolic cages (obtained 
from Acme Metal Products, Chicago) deliver the drinking fluid to the rat 
* The volume of fluid drunk refers to that consumed by individual rats of 
different body weights. There was much less variability in fluid 
consumption when expressed as per 100 g body wei ght. 
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via a spout that reaches into the cage through an opening (3/4 inch in 
diameter) in the back wall. Hence, any spillage of drinking fluid can 
drop into the cage and is automatically collected along with the urine. 
Therefore, the drinking fluid container was moved so that the end of the 
spout was located on the outside of the cage, about 1 inch away from 
the back wall. The opening was enlarged to 1 1/4 inch in diameter, so 
that the rat could reach out and drink, but could not escape. Spillage 
was collected in a small cup placed beneath the spout. 
The rats used in these experiments ate between 13 and 22 g of food 
each day. There was considerable spillage into the urine when cubed rat 
food was used since the rats withdrew the cubes from the feeding dish 
into the cage proper and pieces broken off readily fell into the urine. 
This problem was minimized by grinding the food in a mill. However, 
inevitably, some food (about 1 g/day) found its way into the urine. That 
this could not be a significant artifactual source of ammonia 
(ammonium) in the urine was shown by experiments in which 1 g of food 
was soaked in 15 ml of water for 24 hours. The ammonia, subsequently 
found in the water (by the method of Kirsten et al. (61)) was trival in 
comparison with normal daily excretion (i.e., less than 1%). 
A similar problem involves feces. No device for separating feces 
from urine was present in the metabolic cages used. Therefore, metal 
grids, cut to size, were placed in the collecting funnels. However, 
some feces still dropped into the urine. In addition, it is also pos-
sible that the urine comes in contact with the feces on the metal grid. 
To determine whether feces could be a significant source of ammonia (am-
monium), ground feces was soaked in 15 mls of water in amounts com-
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parable to that found in the collected urine. Again, the ammonia found 
in the water after 24 hours does not represent a significant artifact 
(i.e., less than 1%). 
(2) Evaporation 
The rats used in these experiments excreted between 10 and 20 ml 
of urine each day. The collecting funnels were treated every two or 
three days with ''Siliclad" (silicone) to minimize evaporation of urine. 
"Siliclad" makes the funnels more water repellent and improves drainage. 
The extent of evaporation, which did occur, was estimated by ex-
periments in which the collecting funnels were washed with water after 
24 hr of urine collection. Creatinine was measured in the washes and 
collected urines by a colorimetric method based on the Jaffe reaction 
(26). By comparing the amount of creatinine in the washes with the total 
amount of creatinine excreted, the average evaporation was calculated 
to be 6.8% of the total urine excreted. 
Urine was collected in 30 ml glass tubes. Evaporation of the col-
lected urine was reduced by adding mineral oil to the collecting tubes. 
Mineral oil forms a layer on top of the urine so that the urine is 
not exposed to the air. 
(3) Bacterial Contamination 
No protection against bacterial contamination, other than mineral 
oil, was used. Therefore, it was important to know if ammonia is formed, 
under these conditions, by bacterial degradation of urea or other 
nitrogenous substances. For this purpose, experiments were carried out 
in which one portion of each urine, collected under ordinary conditions, 
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was frozen while the other portion was allowed to stand for 24 hr, 
under mineral oil, in the animal room. The lack of a significant dif-
ference between the differently treated portions is taken as evidence 
that bacterial degradation is not a significant source of urinary 
ammonia. 
C. Studies in vivo 
1. Urine 
(a) Ammonia excretion. Rats were individually placed in carefully 
washed metabolic cages 24 hr prior to the period of urine collection. 
This period was allowed for the rat to become accustomed to the cage. 
The urine was collected under mineral oil for 24 hr. The ammonia in the 
urine was measured, after appropriate dilution, by the method of Kirsten 
et al. (61). 
2. Plasma 
(a) Glutamine arterio-renal venous differences. Rats were 
anesthetized by intraperitoneal injection of sodium pentobarbital (6.5 
mg/100 g body weight). The renal vein and abdominal aorta were exposed 
by midline incision. Blood samples (approximately 1 ml) were withdrawn 
into heparinized plastic syringes, first from the renal vein and then 
from the abdominal aorta. The blood samples were centrifuged and a 
portion of each plasma was added to a half volume of 12% (w/v) HClo4 , 
mixed vigorously with a vortex mixer and allowed to stand on ice for 
15 min. After removing the precipitated proteins by centrifugation, an 
aliquot of each supernatant was added to an equal volume of 0.3 N 
lithium citrate buffer (pH 2.2) and the pH adjusted to 2.2 with 2 N LiOH. 
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Samples of 0.5 ml from the buffered solutions were then used to measure 
glutamine on a Beckman Model 121 Automatic Amino Acid Analyzer (106). 
The concentrations of glutamine from paired samples v ere used to cal-
culate arterio-renal venous differences. 
3. Blood 
(a) pH~ pco2 and [nco;]. Rats were coaxed into a restraining cage 
and, after tail prick with a sharp scalpel, blood samples were drawn 
into 100 ~1 heparinized capillary tubes. Care was taken to minimize 
stress from handling. The capillary tubes were immediately plugged~ 
mixed with a magnetic bar and magnet and placed on ice . The pH and pC02 
were measured as rapidly as possibly and always witbin one hour with 
the model 213 pH Blood Gas Analyzer (Instrumentation Laboratories ). The 
[Hco;] was calculated from the pH and pco2 measurern~lts by the formula: 
antilog (pH - 6.1) 
D. Studies in vitro 
1. Entire Kidney Homogenates 
(a) Preparation of homogenates. The entire right kidney of each 
animal was weighed, chopped into small pieces and suspended in 50 
volumes of ice-cold 0.25 M sucrose containing 3 mM Tris (HCl) buffer 
(pH 7.4), 1 mM EGTA and 0.15 M NaF. The suspensions were then homogenized 
in a smooth glass Potter-Elvehjem homogenizer with a close-fitting motor 
driven Teflon pestle (clearance .15 mm). 
(b) Phosphoenolpyruvate carboxykinase assay. One part of each 
homogenate was centrifuged at 30~000 g and 0° C for 30 min. Aliquots of 
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0.1 ml of the supernatants were then used to assay the activity of 
phosphoenol-pyruvate carboxykinase (PEPCK) in the direction of decarboxy-
lation by a modification of the method of Seubert and Ruth (100). In 
the method used NaF was added to the homogenizing medium instead of to 
the incubation medium. Fluoride ion is included to inhibit phosphatases 
and enolases which can remove nucleoside triphosphate and phospho-
enolpyruvate (PEP), respectively. The effectiveness of NaF was 
demonstrated by recovery experiments in which PEP was added to incubations 
using homogenates with and without NaF. In incubations using homogenates 
without NaF, the recovery of PEP was 94%, while incubations using homo-
genates containing NaF, the recovery of PEP was 100%. Figs. 2(a) and 2(b) 
show the formation of PEP by 2% homogenates prepared from the kidneys 
of normal rats and rats receiving 1.5% (w/v) NH4 Cl for 7 days as 
functions of incubation time (0.1 ml aliquot) and amount of enzyme (15 
min incubation), respectively. The incubation time and amount of 
homogenate used for the measurement of PEPCK activity are within the 
linear range of this assay. 
(c) Phosphate dependent glutaminase assay. Aliquots of 0.1 ml of 
the other part of each kidney homogenate were used, without centrifugation 
to assay phosphate dependent glutaminase (PDG) by the method of 
Curthoys and Lowry (19). It was previously shown that sonication of 
this preparation was not necessary to obtain maximum activity. The in-
clusion of 0.15 M NaF in the homogenates is shown in Table 1 not to affect 
this assay when using kidney homogenates prepared from either normal 
or acidotic rats. 
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Table 1 Effect of NaF on Phosphate Dependent Glutaminase Assay 
GLUTAMATE FORMED ()lmoles) 
0.15M NaF in 
Homogenizing Normal Acidotic 
Medium 
-
0.73 2.16 
+ 0.69 2.16 
This table shows the amount of glutamate formed by 2% (w/v) entire 
rat kidney homogenates (with and without NaF) from a normal rat and 
a rat administered 1.5% (w/v) NH4Cl for 7 days. 
~ Kidney Cortex Mitochondria 
(a) Preparation of mitochondria. The kidneys of each rat were 
demedullated, chopped into small pieces and suspended in 0.25 M 
sucrose containing 5 mM Hepes buffer (pH 7.4) and 1 mM EGTA. Mito-
chondria were prepared by homogenization and centrifugation according 
to the method described by Kalra and Brosnan (56). ~tochondrial 
protein was measured by the biruet method (43) after solubilization 
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of lipid with deoxycholate (55). Bovine serum albumin (fatty acid free) 
was used as a standard. The mitochondrial suspension was then adjusted 
to a protein concentration of between 10 and 15 mg/m1. All operations 
were carried out at 0-4° C. 
(b) Incubation procedure and ammonia production. The following 
is a modification of the incubation procedure used by Hird and 
Marginson (49). Aliquots of 0.1 ml of the mitochondrial suspensions 
(1.0 - 1.5 mg of mitochondrial protein) were incubated with 20 mM 
Hepes buffer (pH 7.4), 2 mM glutamine, 10 mM sucrose (from mito-
chondrial suspension), 0.14 M KCl, 15 mM KH2Po4 , 2 mM MgC12 , 1 mg/ml 
BSA (fatty acid free), 2 mM EDTA, 23 mM glucose, 2 mM ADP and dialyzed 
hexokinase (at least 8 units) all in a final volume of 2.4 ml. The 
incubations were carried out at 30° C in unstoppered 25 m1 Erlenmeyer 
flasks, shaking at a rate of approximately 100 osci11ations per minute. 
After 15 min, the incubations were stopped by the addition of 0.2 m1 of 
70% (w/v) ~c1o4 and neutralized to pH 7.0 with 5 M KOH. The contents 
of the incubation flasks were centrifuged to remove precipitated 
KClo4 and the supernatants used to measure ammonia (ammonium) as de-
scribed below. 
Glucose and hexokinase were added to regenerate ADP from ATP 
produced during the incubation. The yeast hexokinase (purchased as a 
crystalline suspension in 3.2 M ammonium sulfate) was prepared by 
dialyzing with constant stirring at 0° C against 1 liter of 10 mM 
potassium phosphate buffer (pH 7.0). The phosphate buffer was changed 
eight times. The protein concentration of hexokinase after dialysis 
was determined by measuring its absorption at 260 nm and 280 nm. 
The determination of ammonia (ammonium) is complicated by the 
presence of glutamine. Glutamine breaks down non-enzymatically to 
yield ammonia. Therefore ammonium (ammonia) was measured by the 
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following method. This method is based upon that used by Sherrard and 
Simpson (102) for the separation of ammonium from blood and urine. 
Ammonium present in 0.5 ml aliquots of the supernatants (from incubations) 
was absorbed to batches (approximately 0.3 g) of cation exchange resin. 
The resin used was Bio-Rad AG 50W-X8, 50-100 mesh, sulfonic acid type, 
Na form. After washing several times with deionized ammonia free water, 
ammonium was eluted with 1 ml of 2 M CsCl and measured colorimetrically by 
the indophenol reaction (26). Standard curves were constructed by taking 
known quantities of ammonium chloride through the entire procedure de-
scribed above. Figs. 3(a) and 3(b) show the production of ammonia by 
mitochondria isolated from normal rats and rats receiving 1.5% (w/v) 
NH4 Cl for 7 days as a function of incubation time (0.10 ml aliquot) and 
mitochondrial protein (15 min incubation), respectively. The production 
of ammonia is linear under the conditions employed up to at least 1.5 mg of 
mitochondrial protein and 15 min incubation time. 
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(c) Incubation procedure and oxygen consumption. The utilization 
of oxygen by mitochondria was measured with a Clark-type oxygen electrode 
by incubating, at 30° C, aliquots of 0.1 ml of the mitochondrial sus-
pensions in a medium containing 5 inM Tris (HCl) buffer (pH 7.2), 0.14 M 
KCl, 15 mM KE2P04 , 2 mM MgC12 , 2 mM EDTA, 2 mM ADP, l mg/ml BSA (fatty 
acid free) and either 2 IDM glutamine, 2 mM glutamate, 2 mM a-ketoglutarate 
or 2 mM succinate. 
3. Kidney Cortex Slices 
(a) Preparation of slices and incubation procedure. Kidney cortex 
slices of approximately 10-30 mg were cut free-hand by the method of 
Deutch as described by DeLuca (23). Each slice was individually pre-
incubated at room temperature in a saline medium of Krebs Ringer for 10-
15 min. The Krebs Ringer solution was made up such that the concentration 
of Ca++ was equivalent to the concentration of ionized Ca++ in serum. 
This preincubation procedure was carried out to remove preformed glucose 
and glucose produced from endogenous substrates. The slices were then 
blotted free of excess saline, weighed on a torsion balance and placed in 
25 ml Erlenmeyer flasks containing 5 ml of gassed (95% o2 
Henseleit medium and either no substrate (slice blank) or with one of the 
following substrates: 2 mM glutamine, 10 mM oxaloacetate, 10 mM malate, 
10 mM lactate or 10 mM pyruvate. The Krebs-Henseleit medium also contained 
C ++ . 1 h . f .. dC++. a concentrat1on equa to t e concentrat1on o 1on1ze a 1n serum. 
The glutamine concentration used was 2 mM because the results of experi-
ments by Welbourne (110) suggest that higher substrate concentration leads 
to glutamine utilization other than by the glutaminase I pathway. A 
flask containing 2 mM glutamine in 5 ml of gassed Krebs-Henseleit and no 
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slice was used as a glutamine blank. The flasks were then flushed with 
95% o 2 - 5% co2 , stoppered, and incubated at 37° C in a Dubnoff metabolic 
shaker at approximately 100 oscillations per minute~ After 90 min the 
incubations were stopped by the addition of 0.45 ml of 70% (w/v) HC104 . 
The contents of each flask were then homogenized in a smooth glass Potter-
Elvehjem homogenizer with a close-fitting motor-driven Teflon pestle 
(clearance .15 mm) and neutralized to pH 7.0 with 3M K3Po4 . The re-
suiting precipitate was removed by centrifugation. 
(b) Ammonia production, glutamate formation, glutamine utilization 
and glucose production. Ammonium (ammonia) was remove d from 0.1 ml 
aliquots of the supernatants with cation exchange resin, and then measured 
by the indophenol reaction as previously described. Glutamate was 
measured in 0.5 ml aliquots according to the enzymatic method of Bernt 
and Bergmeyer (10). Glutamine was measured in 1.0 ml aliquots of the 
supernatants by hydrolyzing it to pyrollidone carboxylate with heating 
0 (100 C) for 5 min in 2N H2so4 , cooling on ice, and then converting it 
to glutamate by heating (100° C) for 45 min in a final concentration of 
lN KOH. After cooling, the alkaline solutions were then adjusted to 
pH 9.0, centrifuged and 0.1 ml aliquots of the supernatants used to measure 
glutamate by the method described above. The amount of glutamine was 
calculated by subtracting the amount of glutamate present before 
hydrolysis from the amount of glutamate present after hydrolysis. Glucose 
was measured in 2.0 ml aliquots of the supernatants (obtained by cen-
trifuging the incubation m~diums after homogenization and neutralization) 
by the specific glucose oxidase method described in Sigma Technical 
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Bulletin, No. 510. 
E. Statistical Treatment 
Results are expressed as means + standard deviations. The signifi-
cance of differences was calculated by the Student "t" test. "P" values 
of 0.05 or less were taken to indicate a significant difference between 
means. 
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RESULTS AND DISCUSSION 
A. Changes in Renal Ammonia Production 
So as to investigate the mechanisms involved in the regulation of 
ammonia production, it was decided to compare the time course of 
metabolic changes, which are thought to be of regulatory importance in 
the rat, with changes in the production of ammonia in vivo. It was 
therefore necessary to establish the pattern of ammonia production during 
the experiments designed for this study. The protocol ir ·rolved giving 
an acid load by substituting 1.5% (w/v) NH4c1 for drinking water. NH4Cl, 
which is commonly employed for this purpose, is metabolized in the liver 
to hydrochloric acid and urea: 
Since HCl cannot be metabolized further, it must be eliminated from the 
body via the kidneys. It was estimated t hat each rat drank in one day 
about 7 ml of this solu.tion per 100 g body weight*. This means that 
about 2 mmoles of acid per 100 g body weight was taken in each day and 
required excretion. 
1. Urinary Ammonia Excretion 
In general about 75% of the ammonia produced by the kidney is ex-
creted in the urine. The other 25% diffuses into the renal venous 
blood (84). Table 2 shows that the excretion of ammonia in the urine 
is elevated in rats given 1.5% (w/v) NH4Cl. This increase is 
statistically significant at day 1 (P < 0.005 compared to day 0) and 
continued to climb (P < 0.005 day 2 compared to day 1) until day 3 (P < 
* Although the quantity of fluid drunk ~as quite constant during the 
late onset and plateau phases, somewhat less was consumed during the 
first day. However, the slow adaptation in ammonia excretion cannot 
be accounted for by assuming a slow increase in the amount of acid 
consumed. The sharp fall in blood pH on day 7 (Table 4) attests to 
the fact that more acid was consumed t han could be excreted. 
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Table 2 Uninary Ammonia Excretion by Rats after Different Treatments 
TREATMENT UNINARY AMMONIA 
EXCRETION 
Day of Days on Days on 
Treatment NH4Cl Water 
1.5%(w/v) mmoles/24 h/lOOg body wt 
±SD (no of animals) 
0 - (X) 0.30±0.18(12) 
1 1 - 0.70±0.23(6) 
2 2 - 1.37±0.29(7) 
3 3 - 1.91±0.51(7) 
4 4 - 2.03±0.51(7) 
5 5 - 1.81±0.78(4) 
6 6 - 1.84±0.64(5) 
7 7 - 2.22±0.45(10) 
8 7 1 0.74±0.32(6) 
\ 
9 7 2 0.35±0.27(6) 
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0.05 compared to day 2). No further change in ammonia excretion is ob-
served until the NH4Cl was replaced by water. The rates o~ ammonia ex-
cretion for days 5 and 6, however are not signi~icantly different from 
that for day 2. This is probably because of the small number of animals 
used and the large variabili.ty between animals, After day 7, when the 
rats were returned to tap water, ammonia excretion abruptly fell (P < · 
0.001 day 8 compared to day 7) but was still significantly higher than 
normal (P < 0.005). However, since the value reported for day 8 is a 
measure of the ammonia excreted over the previous 24 hours, it is 
probable that the rate of ammonia excretion had returned to normal values 
by the end of day 8. The value reported for day 9 is not significantly 
different from that for either day 8 or day 0. 
The time course of adaptation to administration of NH4 Cl appears 
to vary in different laboratories. In addition, the maximal response 
of ammonia excretion is not consistent with the dose administered. 
Welbourne (111) found. that rats receiving, ad libitum, approximately 
1 mmole/100 g body weight daily, required about 4 days to reach maximum 
rates of ammonia excretion (approximately 4-5 fold above normal). 
Rector et al. (92) found that rats intubated with approximately 1.3 
--
mmoles NH4Cl/100 g body weight each day also required about 4 days to 
reach maximal ammonia excretion, but that the maximal response was only 
about 2 fold above normal. Dies and Lotspeich (25) intubated rats with 
a much larger dose, 3 mmoles NH4Cl/100 g body weight/day, yet their re-
sults show that the increase in ammonia excretion was complete by the 
end of 2 days and increased only 2-3 fold. It is possible that dif-
ferences in diet contribute to the observed differences in ammonia ex-
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cretion. Dies and Lotspeich (25) compared the response of ammonia ex-
cretion to the dose of NH4Cl administered. Their results show that this 
relationship is not linear as might be expected, but rather, curvilinear 
with steeper increases in ammonia excretion occuring at higher doses 
of NH4Cl used. Consequently, it may not be justified to directly com-
pare the response obtained here with those obtained in other laboratories. 
2. Glutamine Arterio-Renal Venous Differences 
It was important to know if the abrupt drop in ammonia excretion on 
day 8 is due to a similarly abrupt fall in ammonia production, or due, 
at least in part, to a diversion of produced ammonia into the renal-venous 
blood. If the latter explanation was true, then it would be expected 
that the animals would become quite sick during recovery. Since this 
did not appear to be the case it was thought likely that the production 
of ammonia did parallel the excretion of ammonia in the urine. To ensure 
that this conclusion was correct, the utilization of glutamine by the 
kidney was measured. This was determined by measuring glutamine 
arterio-renal venous differences. 
Table 3 shows that glutamine A-V differences increase in rats given 
1.5% (w/v) NH4Cl. This increase is statistically significant at day 3 
(P < 0.05 compared to day 0) and remains elevated for the remainder of 
the 1.5% (w/v) NH4Cl regimen. On return to tap water, the glutamine A-V 
differences fell abruptly (P < 0.025 day 8 compared to day 7) to very 
low levels. The negative A-V seen on day 9, although not significantly 
different from zero, may indicate that more glutamine leaves the kidney 
than enters it. This suggests that an increase in the synthesis of 
Table 3 
Day of 
Treatment 
0 
1 
3 
5 
7 
8 
9 
Glutamine Arterio Renal Venous Differences in 
Rats after Different Treatments 
TREATMENT Glutamine Arterio 
Renal Venous 
Days on Days on Differences 
NH4Cl Water 
1.5%(w/v) ~moles/ml plasma ±SD (no of animals) 
-
00 0.067±0.012(4) 
1 - 0.104±0.113(3) 
3 - 0.146±0.046(3) 
5 - 0.147±0.038(3) 
7 
-
0.160±0.057(3) 
7 1 0.016±0.042(5) 
7 2 -0.025±0.034(3) 
NS indicates not significant (P>0.05) 
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P Value (Arterio 
Venous Difference 
Different from 
Zero) 
<0.005 
NS 
<0.050 
<0.025 
<0.050 
NS 
NS 
glutamine from glutamate, via glutamine synthetase, may be involved in 
reducing net ammonia production. 
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Figure 4 compares ammonia excretion with glutamine A-V differences 
of rats after the treatment described in Tables 2 and 3. The 6-7 fold 
increase in ammonia excretion is accompanied by a 2-3 fold increase in 
the utilization of glutamine. The abrupt fall in glutamine A-V dif-
ferences coincides with a similarly abrupt drop in ammonia excretion. 
It is concluded from this correlation that the abrupt drop in ammonia 
excretion is due to an abrupt drop in net ammonia production. 
The response of the kidney in the production of ammonia can now 
be divided into 3 phases (Figure 4). The onset phase lasts for ap-
proximately 3 days during which there is a slow progressive increase in 
ammonia production. The plateau phase begins with the attainment of 
plateau levels of ammonia excretion on day 3 and lasts until the end of 
day 7. The rate of ammonia excretion returns to normal during there-
covery phase which begins at the end of day 7 and is complete by the end 
of day 8. 
B. Changes in Acid-Base Parameters in the Blood 
Blood [H+], [HCO)J and pC02 comprise a group of interrelated para-
meters that define the acid-base status of the animal. It is not un-
reasonable to assume that changes in these parameters could be transmitted 
to the intracellular environment of the cells responsible for producing 
urine ammonia and thus may potentially be of regulatory importance. To 
help assess their role in this regard, it was necessary to know how these 
parameters changed in relation to ammonia production. For this purpose, 
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experiments were performed in which these parameters were measured during 
the different phases of adaptation and recovery. This required taking 
samples of blood from the animals. It was undesirable to use an 
anesthetic because even light anesthesia affects respiration and hence 
alters the pC02 . Instead, blood was sampled, without anesthesia, from 
the tail. To reduce variability the same animals were used throughout 
the experiment. This required that blood be sampled from each rat every 
day for 9 consecutive days. Such treatment could possibly affect 
respiration and cause metabolic changes due to stress. To control for 
this, the acid-base parameters were also determined in a control group 
which was allowed tap water to drink. The animals in the control group were 
handled and the blood sampled in the same manner as the animals of the 
experimental group. 
1. Blood Hydrogen Ion Activity 
Table 4 shows the blood hydrogen ion activity (aH) of the control 
group and the experimental group. The aH values were calculated* from 
measured pH values before determining the mean+ standard deviation (SD). 
In the control group, the aH did not change significantly throughout the 
duration of the experiment. In the experimental group, the aH rose 
sharply during the first day of treatment and remained elevated at this 
level over the next 2-3 days. Thereafter, the ~ gradually returned 
* In the case of blood the ionic strength is sufficiently great that it 
would not be correct to assume that the hydrogen ion activity co-
efficient is equal to 1. Consequently, in order to convert pH to [H+], 
it would be necessary to determine the value of ~he activity coefficient 
which would in turn introduce further error (13). 
Table 4 Blood Hydrogen Ion Activity in Control and Experimental Rats 
CONTROL GROUP EXPERIMENTAL GROUP 
Day Blood ~ P Different Blood ~ P Different P Experimental 
of nEq/l±S from Day 0 nEq/l±S from Day 0 Group Different 
Treatment (no of animals) (no of animals) from Control Group 
0 38.7±2.3(4) 3 9 . 6± 1. 8 ( 8) NS 
1 37.8±3.7(4) NS 54.5±5.9(8) <0.001 <0.001 
2 40.3±3.5(4) NS 57.1±8.6(8) <0.001 <0.01 
3 3 7 • 5± 3 • 1 ( 4) NS 52.9±4.9(8) <0.001 <0.001 
4 3 8 • 2± 1. 4 ( 4) NS 48.0±4.7(8) <0.001 <0.005 
5 36.4±4.7(3) NS 45.8±3.7(8) <0.005 <0.025 
6 38.0±3.3(4) NS 44.5±5.8(4) NS NS 
7 37.7±0.1(4) NS 46.1±3.7(8) <0.001 <0.005 
8 36. 8±1. 6 ( 4) NS 35.6±2.2(8) <0.005 NS 
9 38.3±2.3(4) NS 37.1±2.0(8) <0.05 NS 
The control group drank tap water for the 'duration of the experiment. The experimental 
group drank 1.5% (w/v) NH4Cl for the first 7 days and then was returned to tap water for the remainder of the experiment. NS indicates not significant (P>0.05) 
Ll1 
0 
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towards normal. Day 6 is not significantly differeat from either day 0 
of the experimental group or day 6 of the control group. However, the 
mean for day 6 of the experimental group was calcula ted from only 4 
determinations. Consequently, variability prevents this mean from being 
significantly different from normal. It is expecte~, in light of the 
fact that the ~ for day 7 is still significantly higher than normal, 
that day 6 is also above normal and would prove significant after more 
values are obtained. When the experimental group was returned to tap 
water after drinking 1.5% (w/v) NH4 Cl for 7 days, t~ere was an abrupt 
fall in blood aH from slightly above normal on day 1 to slightly below 
normal on day 8. Although the blood aH on days 8 amd 9 are both lower 
than normal, they are not significantly different f~Qm the blood aH of 
days 8 and 9 of the control group. 
Figure 5 compares blood aH of the control and experimental groups 
with ammonia excretion during the onset, plateau an~ recovery phases. 
It is evident from this comparison that ammonia excretion is not a simple 
function of blood aH. Although it is possible that the elevated blood 
~ during the onset phase is an initial stimulus for the increase in am-
monia production, it is clear that there is no delay in acidification of 
the blood, similar to the time lag for the adaptive increase in ammonia 
excretion. Also, since ~ falls during the plateau phase while the rate 
of ammonia excretion remains elevated, then it wou~ appear that is 
not responsible for the sustained adaptive response. Obviously, the fall 
in blood ~ towards normal during the plateau phase occurs because the 
animal has developed its ability to excrete acid, as a result of its in-
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creased renal capacity to synthesize ammonia. However, it appears that 
~ does not completely return to normal during the plateau phase. 
Therefore, although all is probably not directly responsible for sus-
taining the maximal adaptive response it may be indirectly important for 
continued ammonia excretion. Thus, the further fall in ~ observed 
during the recovery phase may play a role in turning off ammonia pro-
duct ion. 
Masoro and Siegel (70) define acidosis "as an abnormal condition or 
+ process which would produce a fall in the pH or rise in the [H J of the 
blood if there were no secondary changes". These authors further add that 
"since secondary changes which diminish the extent of pH change do occur 
+ it is possible to -have an acidosis with a normal blood pH or H con-
centration~'. Thus, even though the blood ~ has returned to near normal 
within 5 or 6 days, these animals should still be regarded as acidotic. 
2. Blood Bicarbonate Ion Concentration 
Table 5 shows the blood bicarbonate ion concentration [HCO)J in con-
trol and experimental rats. In the control group the [HCO)J increased 
significantly on days 7 and 8. The reason for this is not known. However, 
it is unlikely that these increases can be attributed to errors in their 
measurement since the blood-gas machine was calibrated before each 
determination. It is possible that the method of sampling the blood (i.e., 
by tail prick) contributes to the variation in pC02 • 
In the experimental group the blood [HCO)J drops abruptly during 
the first day of treatment and remains at this level for another 2-3 days. 
Thereafter, the [HCO)J gradually returns to normal by day 5 and remains 
Table 5 Blood Bicarbonate Ion Concentration in Control and Experimental Rats 
CONTROL GROUP EXPERIMENTAL GROUP 
Day Blood [Hco;J P Different Blood [Hco;J P Different P Experimental 
of mEq/1±SD from Day 0 mEq/1±SD from Day 0 Group Different 
Treatment (no of animals) (no of animals) from Control Group 
0 24.2±2.6(4) 24.8±2.2(8) NS 
1 26.3±2.2(4) NS 19.4±4.0(8) <0.01 <0.025 
2 24.3±3.5(4) NS 19.4±3.9(8) <0.01 NS 
3 25.9±2.7(4) NS 19.4±2.4(8) <0.001 <0.005 
4 25.5±2.1(4) NS 21. 2±2. 7 (8) <0.025 <0.05 
5 28.1±3.2(3) NS 23.2±2.4(8) NS <0.05 
6 27.1±2.4(4) NS 25.6±4.3(4) NS NS 
7 29.7±1.4(4) <0.025 23.8±3.7(8) NS <0.025 
8 29.2±2.0(4) <0.05 35.2±1.9(8) <0.001 <0.001 
9 28.0±2.1(4) NS 28.2±3.1(8) <0.05 NS 
The control group drank tap water for the duration of the experiment. The experimental 
group drank 1.5% (w/v) NH4Cl for the first 7 days and then was returned to tap water for the remainder of the experiment. NS indicates not significant (P>0.05) 
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within the normal range for the duration of the 1.5Z (w/v) NH4Cl regimen. 
After day 7, when the rats were returned to tap water, there is a highly 
significant increase in blood [Hco)J~ The reason for this overcom~ 
pensation is not clear. 
Figure 6 compares the blood [HCO)J of the control and experimental 
groups with ammonia excretion during the onset, plateau and recovery 
phases. The blood [HCO)J of the experimental group falls abruptly to a 
minimum during day 1 and remains at this level for the duration of the 
onset phase. Since during the onset phase ammonia excretion only 
slowly increases while no comparable delay in blood [Reo;] changes 
occurs, then it is clear that a rapid direct control of renal ammonia-
genesis by blood bicarbonate cannot be invoked. It is also obvious that 
low blood [Reo;] is not responsible for the sustained adaptive response 
of ammonia production since, during the plateau phase, the [Reo;] returns 
to normal while the rate of ammonia excretion remains elevated. However, 
it is possible that the drop in blood [Reo;] during the onset phase is 
an initial stimulus for the increase in ammonia production. It is also 
possible that the abrupt rise in [Reo;] in the recovery phase is involved 
with turning off the production of ammonia. 
3. Blood Carbon Dioxide Tension 
Table 6 shows the blood carbon dioxide tension (pC02) of the control 
and experimental groups. In the control group, there is a significant 
increase in pC02 on day 7. The reason for this is not known, but it may 
be purely fortuitous. In the experimental group there are significant 
increases in pC02 on days 6 and 8. However, only the pC02 for day 8 
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Table 6 Blood pco2 in Control a:nd Experimental Rats 
CONTROL GROUP EXPERIMENTAL GROUP 
Day Blood pco2 P Different Blood pco2 P Different P Experimental 
of mmHg ±SD from Day 0 mmHg ±SD from Day 0 Group Different 
Treatment (no of animals) (no of animals) from Control Group 
0 39.2±4.0(4) 41. 2±3. 6 (8) NS 
1 41. 7±5 .5(4) NS 43.8±6.1(8) NS NS 
2 40.6±3.5(4) NS 45.5±6.3(8) NS NS 
3 40.6±3.9(4) NS 42.9±4.8(8) NS NS 
4 40.9±3.6(4) NS 42.6±4.7(8) NS NS 
5 42.9±7.8(3) NS 44.4±2.5(8) NS NS 
6 43.3±5.1(4) NS 47.2±3.0(4) <0.05 NS 
7 46.9±3.2(4) <0.05 45.6±4.1(8) NS NS 
8 45.1±4.5(4) NS 51.6±3.0(8) <0.001 <0.025 
9 45.0±3.0(4) NS 43.8±4.4(8) NS NS 
The control group drank tap water for the duration of the experiment. The experimental 
group drank 1.5% (w/v) NH4Cl for the first 7 days and then was returned to tap water for the remainder of the experiment. NS indicates not significant (P>0.05) 
is significantly different from the pco2 for the corresponding day o£ 
the control group. 
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Figure 7 compares the blood pC02 of the control and experimental 
groups with ammonia excretion during the onset, plate au and recovery 
phases. No respiratory adaptation (i.e., decreased pC02 ) during onset 
was observed although it is possible that one occured during the first 
day since pC02 was only measured every 24 hours. During recovery pC02 
increases above normal. This may have been a respiratory response in-
volved in stabilizing the blood [H+] during this phase. Since this in-
crease in pC02 coincides with the return of ammonia excretion to normal, 
it may also be possible that pC02 is involved with turning off ammonia 
production. 
C. Response of Enzymes Involved in the Renal Metabolism of Glutamine 
Phosphate dependent glutaminase (PDG) and phosphoenolpyruvate 
carboxykinase (PEPCK) have both been implicated as rate-determining steps 
in the renal metabolism of glutamine. PDG activity, measured in vitro, 
has been shown to correlate with ammonia excretion in vivo during the 
onset and plateau phases of adaptation (92). Therefore, it was of in-
terest to see what would happen to the activity of this enzyme during the 
recovery phase. The activity of PEPCK has also been shown to increase 
during the onset phase (6). However, the activity of this enzyme has not 
been studied in relation to ammonia production beyond 48 hours o£ acid 
challenge. This is surprising since adaptation of ammonia production can 
take longer than 2 days. It was, therefore, of interest to investigate 
the activity of thisenzyme during adaptation and recovery. 
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Assay of enzyme activities in vitro under opti~l conditions is, in 
effect~ a measure of maximum activities. This does not necessarily bear 
any relation to the activities expressed _in vivo. Bowever, measuring 
maximum activities provides a means of detecting changes in the amount 
of enzyme which is present and presumably capable of catalyzing a 
particular reaction. 
The activities of PDG and PEPCK were measured using entire kidney 
preparations. Entire kidney preparations were employed since it would be 
difficult to quantitatively excise the cortex from all kidneys and also 
such measurements allow calculation of total kidney activities. The 
main disadvantage is that the magnitude of any change is reduced. 
However, this masking is only small since, in the rat, the bulk of the 
kidney is cortex tissue. 
The activity of each enzyme is expressed in 2 ways: first, as 
mmoles/24 hr/g kidney and second, as mmoles/24 hr/100 g body weight . The 
activities were expressed per g kidney to allow comparison with the re-
sults of other investigators, since this is the usua1 mode of expression. 
However, because larger rats do not necessarily have correspondingly larger 
kidneys and because of the relatively wide weight range of rats used, it 
was felt that the activities should also be expressed per 100 g body 
weight. This mode of expression takes into account ~he total activity 
of the enzyme and the work load required of it . It also has the advantage 
of making comparisons with ammonia excretion more meaningful. 
1. Phosphate Dependent Glutaminase 
PDG activity increased in rats drinking 1.5% (w/v) NH4Cl. Table 7 
Table 7 
Day 
of 
Treatment 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
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The Activities of Phosphate Dependent Glutaminase and Phospho-
enolpyruvate Carboxykinase (expressed in mmoles/24h/g kidney) 
in the Kidneys of Rats after Different Treatments 
TREATMENT PHOSPHATE PHOSPHOENOL-
DEPENDENT PYRUVATE 
Days on Days on GLUTAMINASE CARBOXYKINASE 
1.5%(w/v) Water ACTIVITY ACTIVITY 
NH4Cl 
mmoles/24h/g Kidney 
±SD (no of animals) 
-
00 28.3± 3.7(14) 9.2±1.6(15) 
1 - 34.2± 4.3 (5) 19.8±4.9 (7) 
2 - 46.8± 8.8 (6) 25 .1±6 . . 6 (10) 
3 - 64.7±10.7 (6) 28.4±8.3(10) 
4 
-
64.2±12.9 (6) 26.7±7.2 (7) 
5 
-
70.3±16.4 (6) 28.7±7.7 (7) 
6 - 67.4±24.9 (5) 24.6±5.7 (6) 
7 - 78.5±17.7(10) 26.7±6.3(10) 
7 1 85.9±32.9 (5) 12.7±5.3 (5) 
7 2 77.0±40.8 (5) 7.5±1.3 (4) 
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shows the activity of PDG in mmoles/24 hr/g kidney. When expressed in 
these units the increase is statistically significant at day 1 (P < 0.025 
compared to day 0). The activity continued to climb (P < 0.05 day 2 
compared to day 1) to reach a plateau level at about day 3 (P < 0.0025 
compared to day 2). After day 7, when the rats were returned to tap 
water, the activity of PDG remained elevated (P < 0.05 day 8 compared 
to day 2). However, the standard deviation of the mean on day 9 in-
creased such that the activity was significantly dif f erent only from 
that for day 0 (P < 0.001). 
Table 8 shows the activity of PDG expressed in mmoles/24 hr/100 g 
body weight. A similar pattern is observed. However, the increase is 
not statistically -significant until day 2 (P < 0.001 compared to day 0). 
The plateau level was achieved at day 3 (P < 0.050 compared to day 2). 
The activity of PDG remained at plateau levels (P < 0.05 day 8 compared 
to day 2) after the rats were returned to tap water, but again, the 
standard deviations of the means increased such that the means were 
significantly different only from that for day 0 (P < 0.005 for both days 
8 and 9 compared to day 0). 
Figure 8 compares PDG activity with urine ammonia excretion during 
the onset, plateau and recovery phases. There is a good correlation during 
the onset and plateau phases. Significant increases in PDG activity 
occur with significant increases in ammonia excretion. Both reach a 
plateau level by the end of day 3. On the other hand, a marked dis-
sociation is observed during the recovery phase. Whereas PDG activity 
remains at high plateau levels, ammonia excretion abruptly falls to 
normal during this period. It is obvious from this dissociation that, 
Table 8 
Day 
of 
Treatment 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
The activities of Phosphate Dependent Glutaminase and 
Phosphoenolpyruvate Carboxykinase (expressed in mrnoles/ 
24h/100g body wt) in Rats after Different Treatments 
63 
PHOSPHATE PHOSPHOENOLPYRUVATE 
DEPENDENT CARBOXYKINASE 
TREATMENT GLUTAMINASE ACTIVITY 
Days on Days on 
1.5%(w/v) Water mmoles/24h/100g body wt 
NH4Cl ±SD (no of animals) 
-
00 21.6± 4.1(14) 7.0±1.5(15) 
1 - 24.9± 6.4 (5) 15.5±4.6 (7) 
2 - 34.3± 8.6 (6) 17.7±5.6(10) 
3 - 48.0± 9.4 (6) 21.7±6.6(10) 
4 - 50.1±10.1 (6) 20.1±5.6 (7) 
5 - 56.2±15.1 (6) 22.3±7.1 (7) 
6 - 55.4±23.3 (5) 19.8±5.7 (6) 
7 - 60.3±16.2(10) 21.2±6.3(10) 
7 1 62.7±25.2 (5) 9.2±4.0 (5) 
7 2 63.5±42.0 (5) 5.6±0.8 (4) 
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although the measured activity of this enzyme is such that it is capable 
of metabolizing glutamine at the high rates seen during the plateau 
phase, this activity is not expressed in vivo during recovery~ Clearly 
then arnmoniagenesis from glutamine is not regulated solely by the total 
amount of PDG present. 
2. Phosphoenolpyruvate Carboxykinase 
The activity of PEPCK also increased in the kidneys of rats given 
1.5% (w/v) NH4Cl. The activities of both PDG and PEPCK increased ap-
proximately 2-3 fold. Table 7 shows the activity of PEPCK in mmoles/ 
24 hr/g kidney. As seen in this Table, the increase is statistically 
significant at day 1 (P < 0.001 compared to day 0). However, further 
increases over day 1 are significant only on day 3 (P < 0.05), day 5 
(P < 0.05) and day 7 (P < 0.05) and no significant increase over the 
activity of day 2 is observed. Unlike PDG, PEPCK activity fell im-
mediately (P < 0.001 day 8 compared to day 7) when the rats were returned 
to tap water. Although the decrease from day 8 to day 9 is not 
significant, the activity at the end of day 9 is back to that of day 0. 
In Table 8, PEPCK activity is expressed in mmoles/24 hr/100 g body weight. 
When expressed in these units the increase in PEPCK activity is 
significant at day 1 (P < 0.001 compared to day 0), however, no further 
increase over the activity of day 1 is observed, possibly due to the scatter 
of the data. PEPCK activity returns to normal on day 8 (P < 0.001 day 8 
compared to day 7). Although a further decrease occurs on day 9 (P < 
0.005 compared to day 8) the activity of PEPCK at the end of day 9 is not 
significantly different from that of day 0. 
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Figure 9 compares PEPCK activ1 ty with urine amROnia excretion 
during the onses plateau and recovery phases. PEPCK attains maximum 
activity within the first 2 days o~ the 1.5% (w/v) ~4c1 regimen whereas 
ammonia excretion does not reach i t s plateau until the end of day 3. 
Thus, an increase in ammonia excret ion occurs on the third day of 
treatment without a detectable incr ease in PEPCK activity. This dis-
sociation suggests that the maximal activity of PEPCK cannot be the sole 
rate-limiting step for the product i on of ammonia during this phase. On 
the other hand, the abrupt fall in ammonia excretion during the recovery 
phase coincides with a similarly a b rupt drop in PEP~ activity. This 
correlation is consistent with an important role for this enzyme in 
regulating ammonia production durin g recovery. 
D. Effect of Fasting on Urine Ammonia Excretion, Pb®sphate Dependent 
Glutaminase and Phosphoenolpyruvate Carboxykinase During the Recovery 
Phase 
The marked correlation between PEPCK activity amd urine ammonia 
excretion is consistent with this enzyme playing a xmle in the regulation 
of ammonia production during the recovery phase. It is also well known 
that starvation is accompanied by an increase in remal PEPCK activity 
(45, 54). It was therefore of interest to examine tfue effect of fasting 
during the recovery phase on ammonia excretion, PDG activity and PEPCK 
activity. 
1. Starved Control 
To serve as a control, rats were deprived of faod for 24 and 48 
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hours. Table 9 shows the urinary ammonia excretion, PDG activity and 
PEPCK activity after this treatment. No change in urinary ammonia ex-
cretion is observed. There is a decrease in PDG activity after 24 hours 
of fast~ng. The P value for day 1 compared to day 0 is < 0.05 when 
the activity is expressed per g of kidney and is < 0 . 025 when expressed 
per 100 g body weight. However, after 48 hours of fasting, the activity 
of PDG is not significantly different from either day 0 or day 1. 
Therefore, it is quite probable that the small drop in PDG activity after 
24 hours is due to the large variability between animals and the small 
number of rats used in this study, rather than to the effect of fasting. 
PEPCK activity increases after 24 hours of fasting. The P value for day 
1 compared to day 0 is < 0.005 when PEPCK activity is expressed per g 
of kidney and is < 0.025 when expressed per 100 g body weight. No further 
increase in activity above that attained by the end of day 1 is observed. 
2. Starved Recovery 
Table 10 shows ammonia excretion, PDG activity and PEPCK activity 
in rats which, after drinking 1.5% (w/v) NH4Cl for 7 days, were returned 
to tap water and deprived of food for 24 and 48 hours. The urinary am-
monia excretion fell abruptly after the 1.5% (w/v) NH4 Cl was removed 
(P < 0.001 day 8 compared to day 7) but was still significantly higher 
than normal (P < 0.005) on day 8. Although there was no further 
significant drop, the ammonia excretion on day 9 was back to normal. 
The activity of PDG remained elevated at high plateau levels. The 
P values for days 8 and 9 compared to day 0 in both modes of expression 
are < 0.001. PEPCK activity dropped after the rats were returned to tap 
Table 9 Urinary Ammonia Excretion and the Renal Activities of Phosphate Dependent Glutaminase 
and Phosphoenolpyruvate Carboxykinase in Rats during Starved Control 
URINARY 
AMMONIA PHOSPHATE DEPENDENT PHOSPHOENOLPYRUVATE 
TREATMENT EXCRETION GLUTAMINASE ACTIVITY CARBOXYKINASE ACTIVITY 
nnnoles/24h/ nnnoles/24h/ nnnoles/24h/ nnnoles/24h/ rnmoles/24h/ 
Day of lOOg body wt g kidney lOOg body wt g kidney lOOg body wt 
Treatment 
. 
±SD (no of animals) 
0 Normal 0.30±0.18(12) 28.3±3.7(14) 21.6±4.1(14) 9. 2±1. 6 (15) 7. 0±1. 5 (15) 
-
1 Starved(24h) 0.36±0.24(10) 23.2±1.9 (3) 15.0±1.2 (3) 14. 8±4. 4 (3) 9.6±2.9 (3) 
2 Starved(48h) 0.32±0.16(11) 23.4±2.9 (3) 16. 2±1. 3 (3) 14.4±3.0 (3) 9.9±1.8 (3) 
Table 10 Urinary Ammonia Excretion and the Renal Activities of Phosphate Dependent Glutaminase and 
Phosphoenolpyruvate Carboxykinase in Rats during Starved Recovery 
URINARY 
AMMONIA PHOSPHATE DEPENDENT PHOSPHOENOLPYRUVATE 
TREATMENT EXCRETION GLUTAMINASE ACTIVITY CARBOXYKINASE ACTIVITY 
mmoles/24h/ mmoles/24h/ mmoles/24h/ mmo1es/24h/ mmo1es/24h/ 
Day of Days on Days on 100g body wt g kidney lOOg body wt g kidney 100g body wt 
Treat- 1.5%(w/v) Water 
ment NH4C1 ±SD (no of animals) 
7 7 - 2.22±0.45(10) 78.5±17.7(10) 60.3±16.2(10) 26.7±6.3(10) 21.2±6.3(10) 
8 7 1(starved) 0.80±0.31 (4) 86.0±18.3 (4) 80.4±23.8 (4) 16.9±5.3 (5) 15.7±6.7 (5) 
9 7 2(starved) 0.52±0.23 (4) 81.1± 9 . 9 ( 3) 67.0±13.5 (3) 14.5±2.0 (5) 11. 6±1. 0 (5) 
--J 
0 
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water, but remained elevated above normal. This fal l in activity is 
significant after 1 day on tap water (P < 0.025 compared to day 7) when 
the activity is expressed per g of kidney. No further significant drop 
is observed when expressed in these units. The P values for days 8 and 
9 compared to day 0 are both < 0.001. When PEPCK activity is expressed 
in mmoles/24 hr/100 g body weight, the drop in activity is not 
significant until day 9 (P < 0.010 day 9 compared to day 7). The P 
value for day 9 compared to day 0 is < 0.001. 
Figure 10 compares the effect of fasting on urine ammonia excretion 
with the effect of fasting on PDG activity during the recovery phase. 
Ammonia excretion during starved recovery returns to normal with the 
same time course as ammonia excretion during fed recovery. Similarly, 
PDG has the same maximal activity during starved recovery as it does 
during fed recovery. Therefore, the same relationship between ammonia 
excretion and PDG activity exists in the starved recovery as it does in 
the fed recovery. 
Figure 11 compares the effect of fasting on ammonia excretion with 
the effect of fasting on PEPCK activity. PEPCK activity, instead of 
returning to normal as it does in the fed recovery, drops from high 
plateau levels to starved control levels, which are significantly higher 
than normal. The P value for day 9 of the starved recovery compared to 
day 9 of the fed recovery is < 0.005 when expressed per g kidney and < 
0.001 when expressed per 100 g body weight. In the starved control study, 
elevated PEPCK activity was not accompanied by an increase in ammonia 
excretion. In this starved recovery study, despite the elevated PDG 
activity, increased PEPCK activity is still not accompanied by increased 
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urine ammonia. The lack of a correlation between PEPCK activity and 
urine ammonia excretion is inconsistent with this enzyme being a sole 
rate-determining step in ammonia production. The possib~lity still 
exists that the production of ammonia is increased but that the increased 
amount of ammonia formed is not trapped in the urine. However, this is 
considered unlikely. It seems pointless for the rat to have evolved a 
control mechanism which would allow large amounts of highly toxic ammonia 
to be released into the systemic circulation. 
E. Recovery from the NH4Cl Regimen before the Acid-Base Status of the 
Animal had an Opportunity to Improve 
The abrupt drop in urine ammonia excretion, found in the present 
work, agrees with the results of Dies and Lotspeich (25). In both 
studies, rats had been kept on NH4Cl long enough so that the plateau 
phase of ammonia excretion had been established for at least 2 days. 
Blood [Hco)J and pH measurements indicate that it is during this phase 
that the acid-base status of the animal improves. Therefore, it seemed 
possible that by the time the NH4Cl was removed, the acid-base status of 
the animal had returned, almost to normal, such that continued excretion 
of ammonia during the recovery phase was not required. 
In contrast, in experiments with humans (80, 114) high levels of 
ammonia were excreted in the urine for several days after the NH4Cl 
regimen was discontinued. However, it appears that in these experiments 
the urine ammonia excretion was continually increasing over the duration 
of NH4Cl injestion (4 or 5 days). It was, therefore, suspected that the 
ammonia excretion had not yet achieved a plateau phase or possibly had 
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just reached the plateau phase. Thus, since the onset phase is a 
situation where there is an excess of acid injestion over acid ex-
cretion, there would be an excess of acid in the body fluids and tissues. 
Consequently, it was thought that, when the NH4Cl regimen was terminated, 
continued ammonia excretion was required to restore acid-base balance 
(i.e., to excrete excess acid and restore body sodium). The results of 
an experiment by Wood (115) support this conclusion. In his experiment 
NH4Cl was administered to a human for 44 days. During recovery ammonia 
excretion fell much more abruptly than it did during recovery in ex-
periments in which NH4Cl was administered for only 4 or 5 days (80, 114). 
Therefore, it was of interest to follow ammonia excretion in the rat 
during a recovery from a regimen of 1.5% (w/v) NH4Cl before the acid-
base status of the animal had an opportunity to recover during the plateau 
phase. 
1. Early Recovery 
It was shown in previous experiments that the plateau phase is not 
achieved until about the end of the third day of the 1.5% (w/v) NH4Cl 
regimen. Therefore, in order to study recovery before the plateau phase 
had been well established, rats were returned to tap water after only 3 
days on 1.5% (w/v) NH4Cl. Table 11 shows the time course for the return 
of ammonia excretion to normal. The fall in ammonia excretion is not 
significant until day 5 (P < 0.005 compared to day 3). Although the dif-
ference between day 4 and day 5 is not significant, the P value is less 
than 0.10. Since the standard deviation for day 5 is relatively large, 
it is likely that this difference would prove significant if more rats 
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Table 11 Uninary Ammonia Excretion in Rats during Early Recovery 
TREATMENT UNINARY AMMONIA 
EXCRETION 
Day Days on Days on 
mmoles/24h/100g body wt 
of 1.5%(w/v) Water 
Treatment NH4Cl 
±SD (no of animals) 
3 3 - 1.91±0.51(7) 
4 3 1 1.80±0.75(4) 
5 3 2 0.77±0.22(4) 
6 3 3 0.53±0.27(4) 
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are used. The ammonia excretion for day 5 is still signi~icantly higher 
than normal (P < 0~005), However, the rate of ammonia excretion is prob-
ably back to normal by the end of day 5 since the value for this day is, 
of course, the cumulative excretion during the previous 24 hours. 
Ammonia excretion for day 6 is no longer significantly different from 
normal although the drop from day 5 to day 6 is not statistically 
significant. 
Figure 12 compares the return of ammonia excretion to normal during 
recovery in rats after drinking 1.5% (~/v) NH4Cl for 3 days with that 
during recovery in rats after drinking 1.5% (w/v) NH4 Cl for 7 days. The 
earlier recovery takes a day longer than does the later recovery. This 
suggests that the persistence of elevated levels of ammonia excretion 
in the recovery phase is necessary to restore the acid~base balance of 
the animal. 
F. Response of Kidney Cortex Mitochondria 
In the rat kidney PDG is located inside the mitochondrion (20, 56) 
whereas PEPCK is situated primarily in the cytosol (27). Therefore, 
isolated mitochondria afford a means of studying the metabolism of 
glutamine via PDG, in situ, unaffected by the influence of PEPCK. This 
level of organization also provides a system with some physiological 
integrity, so that the metabolism of glutamine can be studied as it may 
be affected by mitochondrial activators and inhibitors, transport pro-
cesses and competing pathways. 
The metabolism of glutamine by isolated mitochondria was studied in 
2 ways: first, by measuring the production of ammonia from glutamine 
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and second, by measuring oxygen consumption during t h e metabolism of 
glutamine and related substrates (glutamate, ~~ketoglutarate and 
succinate). The object of measuring oxygen consumption was to allow 
comparison between glutamine metabolism and the metabolism of the other 
mitochondrial substrates. In both studies the incubation temperature 
was 30° C. This temperature was used, although unphysiological, because 
higher temperatures have been shown to uncouple isolated mitochondria 
(12). 
1. Ammpnia Production 
Table 12 shows that the capacity of mitochondria to produce ammonia 
from glutamine is elevated in mitochondria isolated from rats given 
1.5% (w/v) NH4Cl. This increase is statistically significant after 1 
day of treatment (P < 0.001 compared to day 0). Plateau levels were 
achieved by day 3 (P < 0.001 day 3 compared to day 1). After day 7, 
when the rats were returned to tap water the mitochondrial ammonia pro-
duction remained elevated above normal (P < 0.005 for days 8 and 9 com-
pared to day 0), but was no longer significantly higher than that for 
day 1. Although days 8 and 9 are not statistically significantly lower 
than day 7, the P values of less than 0.10 tend to suggest a possible 
drop in mitochondrial ammonia production. 
Figure 13 compares the rate of ammonia production by isolated 
mitochondria from glutamine with the rate of ammonia excretion in vivo 
during onset, plateau and recovery. There is a good correlation between 
ammonia production and ammonia excretion during the onset and plateau 
phases. Both increase significantly on the first day and continue to in-
Table 12 
Day of 
Treatment 
0 
1 
3 
5 
7 
8 
9 
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Ammonia Production from Glutamine ( 2m~) by Kidney Cortex 
Mitochondria from Rats after Different Treatments 
TREATMENT AMMONIA 
PRODUCTION 
Days on Days on 
NH4Cl Water mmoles/ 24 h/100 mg 
1.5%(w/v) mitochondrial protein 
±SD (no of animals) 
-
00 2.7::0.5(5) 
1 - 5.2±0.6(6) 
3 - 8.8±1.5(3) 
5 - 8.3±0.3(3) 
7 - 10.2±2.7(5) 
7 1 6.9±2.1(5) 
7 2 6.6±1.8(5) 
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crease until day 3. However, whereas the increase in ammonia excretion 
is 6~7 fold, the increase in ammonia production is only 2-3 fold~ This 
could be taken to indicate that an extramitochondrial event may be 
required for full expression o f the mitochondrial c apacity or it could 
possibly mean that an increase in extramitochondrial ammonia production 
may also be an important part of the adaptive response. 
In the recovery phase a lack of correlation exists. Mitochondrial 
ammonia production remains elevated at above normal levels, whereas am-
monia excretion drops abruptly to normal during this phase. This dis-
sociation suggests that the regulation of ammonia production is not 
brought about solely by alterations in the mitochondrial capacity to 
metabolize glutamine. 
2. Oxygen Consumption 
Kidney cortex mitochondria isolated from rats d rinking 1.5% (w/v) 
NH4Cl have a greater capacity to metabolize glutamine. This was shown 
in studies measuring mitochondrial ammonia production. This is also 
evident from studies in which oxygen consumption was measured. Table 
13 shows that oxygen consumption, using glutamine as substrate, is in-
creased in mitochondria isolated from rats drinking 1.5% (w/v) NH4Cl. 
This increase is statistically significant at day 1 (P < 0.025 compared 
to day 0). However, no further significant increase over day 1 is ob-
served. This lack of a further significant increase may be due to the 
fact that the process being measured (i.e., oxygen consumption) is 
relatively far removed from the actual hydrolysis of glutamine, so that 
significant changes in the metabolism of glutamine may not involve 
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~ignificant ch~nges in oxygen consumption. In any case, it is evident 
that an increase in glutamine metabolism is ~eflected by an increase in 
oxygen consumption. It is also evident that the capacity of isolated 
mitochondria to metabolize glutamine remains elevated during the re-
covery phase. The P values comparing ammonia production for days 8 and 
9 with that of day 0 are both < 0.001, 
Table 13 also shows oxygen consumption by isolated mitochondria 
using glutamate, a-ketoglutarate and succinate as substrates. No 
adaptive change in the metabolism of these substrates is observed. 
Glutamine and glutamate are metabolized by mitochondria from control rats 
at approximately the same rate. However, glutamine is metabolized at a 
much faster rate than glutamate by mitochondria isolated from rats 
drinking 1.5% (w/v) NH4Cl. Since removal of intramitochondrial glutamate 
is required for the oxidation of glutamine, it is probable that the 
transport of glutamate into mitochondria is the rate-limiting step for 
its metabolism. This being the case, then the lack of a detectable 
cpange in the metabolism of glutamate by isolated mitochondria cannot be 
taken to mean that the metabolism of intramitochonrial glutamate is not 
accelerated during adaptation. 
Figure 14 compares the rate of oxygen consumption by isolated mito-
condria, using glutamine as substrate, with in vivo utilization of 
glutamine by the kidney. The major point of interest in this comparison 
is that glutamine metabolism by isolated mitochondria, as reflected by 
oxygen consumption, remains elevated during the recovery phase whereas 
in vivo glutamine utilization falls abruptly. This implies that although 
mitochondria isolated from rats during the recovery phase retain the 
Table 13 Oxygen Consumption During the Metabolism of Glutamine and Related Substrates 
by Kidney Cortex Mitochondria from Rats after Different Treatments 
TREATMENT OXYGEN CONSUMPTION 
Day Days on Days on Glutamine Glutamate aKetoglutarate Succinate 
of 1.5%(w/v) Water (2rnM) (2mM) (2mM) (2mM) 
Treatment NH4Cl 
ng atoms 0/min/mg mitochondrial Protein ±SD (no of animals) 
' 
0 
-
00 18.2± 9.6 (8) 12.5± 7.9 (8) 61. 9±18. 3 (8) 61. 7±16. 8 (8) 
1 1 - 34.6±13.4(12) 12.9± 6.3(12) 71.1±14. 0 (12) 46.3±10.4(12) 
3 3 - 45.0±11.1 (9) . 14.8±10.5 (9) 78.2± 8.6 (9) 54.4±15.9 (9) 
5 5 - 34.1± 7.3 (9) 10.6± 5.8 (9) 57.2±28.8 (9) 51. 7±13. 4 (9) 
7 7 - 38.5±14.1 (8) 10.1± 6.3 (8) 63.0±25.6 (8) 46.9± 8.3 (8) 
8 7 1 43.8± 8.4 (7) 12.6± 5.1 (8) 68 .1±11. 2 (8) 59.6±17.8 (8) 
9 7 2 42 . 4± 5.6 (8) 12.9± 5.5 (8) 73.7±28.8 (8) 62.8±10.0 (8) 
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capacity to metabolize glutamine at the high rates seen during the 
plateau phase, this capacity is not expressed in vivo and must be con-
trolled by some other means. 
G. Response of Kidney Cortex Slices 
86 
The next level at which the metabolism of glutamine was studied is 
the intact kidney cortex slice. The tissue slice has the advantage in 
that it is thought to represent organized surviving tissue, the metabolism 
of which reflects that of the original tissue. Kidney slices, however, 
still suffer from the one major drawback from which nearly all bio-
chemical work on the kidney suffers; that is, the kidney is a highly 
heterogenous organ and slices a~ the kidney inevitably comprise many 
different cell types. From the results of the previous experiments, 
studying changes which occur during the recovery phase proved to be an 
interesting approach. The correlations and dissociations between 
isolated steps in the metabolism of glutamine and in vivo ammonia pro-
duction shed some new light on the problem of how renal ammoniagenesis 
is regulated. It was, therefore, felt appropriate to study how 
glutamine metabolism responded during the recovery phase at the level of 
the intact cell. At this cellular level the in vitro metabolism of 
glutamine would be expected to best approximate the metabolism of 
glutamine in vivo. 
1. Glutamine Metabolism 
The metabolism of glutamine by kidney cortex slices was followed by 
measuring the utilization of glutamine and the production of its major 
products; ammonia, glutamate and glucose. Table 14 shows that the 
Table 14 Metabolism of Glutamine (2mM) by Kidney Cortex Slices from Rats after Different Treatments 
TREATMENT GLUTAMINE AMMONIA GLUTAMATE GLUCOSE 
UTILIZATION PRODUCTION FORMATION PRODUCTION 
Day Days on Days 
of 1.5%(w/v) on ~moles/90 min/g wet wt ± SD (no of animals) Treatment NH4Cl Water ~ 
0 - 00 78.1±13.4(5) 106.0±14.8(5) 13.6±6.1(5) 4.6±1.6(5) 
7 7 - 248.8±42.8(3) 196.3±41.4(4) 28.2±4.3(3) 39.7±4.6(4) 
8 7 1 112.7±68.3(5) 112.9±19.4(5) 13.8±3.1(5) 19. 6±1. 0 (3) 
9 7 2 85.4±16.3(2) 94.9±22.6(4) 14.0±2.6(4) 8.9±1.9(4) 
• 
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metabolism of glutamine is faster in kidney slices taken from 7ats 
given 1~5% (w/v) NH4 Cl than in slices taken from the kidneys o£ control 
rats. This elevated rate of metabolism abruptly fe11 after the rats 
were returned to tap water. 
(?) Glutamine utilization. The utilization of glutamine was in-
creased approximately 3 fold (P < 0,001 day 7 compared to day 0) in 
kidney slices taken from rats drinking 1.5% (w/v) NH4 Cl for 7 days. 
When the rats were returned to tap water, glutamine utilization fell 
abruptly back to normal (P < 0.050 for days 8 and 9 compared to day 7). 
Figure 15 compares the ~n vi~o utilization of glutamine by the kidney 
with the in vitro utilization by kidney cortex slices during the re-
covery phase. Both drop 2-3 fold, returning the utilization of glutamine 
back to normal by the end of day 8. 
(b) Ammonia production. The production of ammonia from glutamine 
by kidney cortex slices, taken from rats drinking 1.5% (w/v) ~H4Cl for 
7 days increased approximately 2 fold (P < 0.010 day 7 compared to day 
0). The increase in in~ ammonia excretion is in the order of 6-7 
fold. This discrepency suggests a lack of physiological integrity in the 
slices and clearly needs explaining. Very recently l.Jelbourne. et al. (113) 
observed that the 2 fold elevation in ammonia production by kidney cortex 
sli.ces taken from rats administered NH4 ci was greatly increased (compared 
with control slices) when the incubation time was lowered fran 45 minutes 
to 15 minutes, He also observed, on the basis of dry to wet ~eight ratios, 
that swelling occurs in slices incubated longer than 15 minutes. On the 
basis of these observations, Welbourne suggests that after 15 minutes in-
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cubation the swelling of the tissue slices activates the mitochondrial 
glutaminase I pathway, such that the difference bet"t:veen control slices 
and slices taken from acidotic rats is much less. Such a non-
physiological activation in vitro would, therefore, mask the magnitude 
of the in vivo activation. Accordingly, the tissue slice appears not to 
reflect the true physiological situation. The perfused kidney is pro-
bably a better system since the in vivo increase in ammonia excretion 
can be exactly duplicated (110). 
Figure 16 compares in vivo ammonia excretion with in vitro ammonia 
production by kidney cortex slices during the recovery phase. Although 
the production of ammonia by the tissue slice does not behave physio-
logically in quantitative terms, it does qualitatively coincide with 
ammonia excretion in vivo. Both are back to normal by the end of day 
8. This would tend to discount the importance of the "plasma factor" 
of Alleyne and Roobol (5) in regulating renal ammonia production, 
especially if the action of the putative factor is of short duration. 
(c) Glutamate formation. Glutamate formation was also examined 
(Table 14). Increased glutamate formation was evident in the acidotic 
animals (P < 0.025 day 7 compared to day 0) and this increase had dis-
appeared on day 8. The increased glutamate accumulation in acidosis 
would tend to indicate that the removal of glutamate may not keep pace 
with its formation. However, since glutamate is released by neither 
the normal kidney or the acidotic kidney in vivo (106), this glutamate 
accumulation may again indicate the unphysiological handling of glutamine 
by slices. 
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(d) Glucose production. Gluconeogenesis increases substantially 
(Table 14) in kidney slices taken from rats drinking 1.5% (w/v) NH4 Cl 
(P < 0,001 day 7 compared to day 0)~ When the rats were returned to 
tap water glucose production fell significantly on day 8 (P < .005 com-
pared to day 7) and continued to fall on day 9 (P < .001 compared to 
day 8). It is probable that glucose production is back to normal by 
the end of day 9. Figure 17 compares glucose production by kidney 
cortex slices with the activity of PEPCK in vitro dur i ng the recovery 
phase. The fall in glucose production coincides with the fall in 
PEPCK activity. This is as expected since PEPCK is thought to be the 
rate-limiting enzyme for renal gluconeogenesis. This correlation is 
also consistent with the PEPCK-gluconeogenesis hypothesis for the 
regulation of renal ammonia production. 
2. Metabolism of Related Substrates 
(a) Glucose production. Kidney cortex slices were also used to 
measure glucose production from other substrates (oxaloacetate, malate, 
lactate and pyruvate). This study was possible because tissue slices 
from the kidney are permeable to these substrates. Each one of these 
substrates is thought to share part of the pathway for the metabolism 
of glutamine. Lactate and malate are on the same oxidation level as 
glucose. Consequently, the reducing equivalents required for reversal 
of the triosephosphate dehydrogenase step can be supplied via cytoplasmic 
reactions. In the case of malate, the enzyme required to generate the 
reducing equivalents is malate dehydrogenase. This enzyme converts 
malate to oxaloacetate. Conversion of oxaloacetate to glucose is 
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probably part of the pathway for gluconeogenesis from glutamine. In 
the case of lactate, the enzyme required to generate the reducing 
equivalents is lactate dehydrogenase. Lactate dehydrogenase converts 
lactate to pyruvate. However, conversion of pyruvate to glucose re~ 
quires participation of mitochondrial enzymes. This means that pyruvate 
is probably converted inside the mitochondrion to oxaloacetate (pyruvate 
carboxylase) and then to aspartate (glutamate oxaloacetate transaminase) 
which leaves the mitochondrion to regenerate cytopla smic oxaloacetate 
(96). This oxaloacetate is converted to phosphoenolpyruvate and then 
to glucose. The conversion of intramitochondrial oxaloacetate to 
cytoplasmic phosphoenolpyruvate is probably part of the pathway for 
conversion of glutamine to co2 and H2o. 
On the other hand, the substrates pyruvate and oxaloacetate are 
more highly oxidized than glucose and consequently require, in their 
conversion to glucose, mitochondrially produced reducing equivalents to 
reverse the triosephosphate dehydrogenase step. In the case of pyruvate, 
this is probably accomplished by intramitochondrial conversion to 
oxaloacetate (pyruvate carboxylase) and then reduction via malate de-
hydrogenase to malate (96). The malate so formed can then pass into 
the cytosol where it is converted to oxaloacetate by cytoplasmic malate 
dehydrogenase, thus generating the cytoplasmic reducing equivalents at 
the expense of intramitochondrial reducing equivalents. In the case of 
oxaloacetate as substrate, it may first be converted to pyruvate (phos-
phoenolpyruvate carboxykinase and pyruvate kinase) which then follows the 
same route to glucose as the substrate pyruvate. However, oxaloacetate 
may also enter the mitochondrion itself, where it is reduced to malate 
95 
(malate dehydrogenase) which then leaves the mitochondrion and is con~ 
verted back to oxaloacetate, thus generating cytoplasmic reducing 
equivalents. With both substrates (pyruvate and oxaloacetate), con~ 
version o~ intramitochondrial malate t~ glucose occurs 1 which is probably 
part o~ the pathway for gluconeogenesis from glutamine. 
Table 15 shows the production of glucose by kidney cortex slices 
from each of these substrates. There are significant increases in 
glucose production from oxaloacetate (P < 0.05), lactate (P < 0.005 and 
pyruvate (P < 0.025) by slices taken from the kidneys of rats drinking 
1.5% (w/v) NH4 Cl for 7 days compared to control slices. Such increases 
are expected since these substrates are converted to glucose via PEPCK. 
Glucose production from malate was also elevated but this elevation is 
not statistically significant. 
There are significant decreases in glucose production from malate 
(P < 0.025), lactate (P < 0.050) and pyruvate (P < .025) by kidney 
slices taken from rats on day 8 compared with slices taken from rats on 
day 7. Glucose production from malate and pyruvate are back to normal 
by the end of day 8. Gluconeogenesis from lactate is back to normal 
by the end of day 9 (P < 0.025 day 9 compared to day 8). Although 
glucose production from oxaloacetate does not significantly decrease on 
day 8, it is back to normal by the end of day 9 (P < 0.05 day 9 compared 
to day 7). 
Figure 18 compares glucose production from oxaloacetate, lactate, 
pyruvate and malate with glucose production from glutamine during the 
recovery phase. The return to control values of gluconeogenesis from all 
five substrates followed a similar time course. This suggests that the 
Table 15 Glucose Production from Various Substrates by Kidney Cortex Slices 
from Rats after Different Treatments 
TREATMENT GLUCOSE PRODUCTION 
Day Days on Days on Oxaloacetate Malate Lac ate 
of 1.5%(w/v) Water (lOmM) (lOmM) (lOmM) 
Treatment 
Pyruvate 
(lOmM) 
NH4Cl ~moles/90 min/g wet tissue wt ±SD (no of animals) . 
0 - 00 14.3± 5.3(4) 42.2± 5.1(4) 12.2±5.4(5) 44.8± 8.3(5) 
7 7 - 36. 6±11. 5 (3) 51.8±11.0(4) 37.9±8.4(4) 120.5±27.9(4) 
8 7 1 23.9± 8.5(3) 35.4± 6.1(4) 24.9±3.8(5) 63.8±19.0(5) 
9 7 2 11. 4 ± 7 • 8 ( 4) 28.l:t 9.5(3) 16.2±3.2(4) 49.0+15.2(4) 
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Related Substrates by Kidney Cortex S l ices during the 
Recovery Phase 
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factor responsible for the return to normal is common to the gluconeo~ 
genic pathway of all five substrates. In view of the similar time 
course in the return of PEPCK to control levels (Fig. 17), it seems 
probable that decreases in gluconeogenesis is brought about by the 
decrease in PEPCK. 
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GENERAL DISCUSSION 
A. Complexity of Ammonia Regulation 
For an animal to survive an acid challenge, the kidney must be 
capable of dealing with the acid load on both an immediate, acute basis 
and on a long term, chronic basis. The kidney deals with the need to 
excrete increased amounts of strong acid on an acute basis by increasing 
the rate of ammonia production within the pre-existing capabilities of 
the metabolic steps involved. This might be accomplished by increasing the 
substrate level of glutamine in the renal tubular cells or possibly by 
altering the concentration of activitors or inhibitors. As well, con-
version of an inactive to an active protein could serve to regulate the 
production of ammonia on an acute basis. Such changes occur rapidly and 
do not require changes in amount of specific proteins. Effectively, they 
involve an increase in the activity of the step which is rate-determining 
under steady~state conditions. The kidney deals with the need to ex-
crete increased amounts of strong acid on a chronic basis by increasing 
the capacities of the slower steps in the metabolic sequence for ammonia 
production. Increasing the capacities presumably involves increasing 
the total protein responsible for carrying out these steps. These chronic 
changes require more time. The rate-determining step during chronic 
adaptation need not necessarily be the same as the rate-determining step 
during acute adaptation. 
An important part of these renal mechanisms must be an ability to 
cope with the termination of the strong acid load. Normal blood levels 
are already close to half the values at which ammonia toxicity begins (46). 
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Since ammonia which is not trapped in the urine will diffuse into the 
blood, then in order to survive termination of a st~ong acid challenge, 
a control mechanism must exist, whereby the production of ammonia is 
closely coupled to its excretion in the urine. 
Although the control of ammonia production appears to be rather com-
plex, the proposed hypotheses are, in principal, relatively simple. It 
should be recognized that although postulating simple mechanisms of 
control is initially appropriate from an experimental point of view, it 
may not be appropriate from a theoretical point of v1ew. It is easier 
to test simpler hypotheses than more complex ones. Theoretically, 
however, it may not be appropriate because living organisms, through the 
evolutionary process, often deliberately favoured the more complex 
systems of control since the flexibility of these s ystems made the 
organism more adaptable. None of the proposed hypoth eses alone account 
for the changes observed in ammonia excretion during both the onset and 
recovery phases. This does not necessarily mean that the hypotheses are 
invalid. It may also mean that more than one regulatory step exists. 
Therefore, on the basis that the previously discuss·ed hypotheses describe 
the three most likely rate determining steps, it should be possible to 
construct a model for the regulation of ammonia production during onset 
and recovery, using where justified the features of more than one 
hypothesis. Such an approach is probably more appropriate than trying to 
fit the results of the present work within the narrnw confines of one 
particular hypothesis. However, it is recognized that other regulatory 
steps may exist whose importance is not currently a~preciated. 
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B. Model for Regulation of Ammonia Production 
The adaptive changes which occur in the kidney in response to an 
acid challenge can be divided into two types: (1) mitochondrial (i.e., 
increases in glutamine transport and in amounts of PDG) and (2) ex-
tramitochondrial (i.e., increases in amounts of PEPCK). Apparently, in 
the rat~ both responses are required for the kidney to reach maximal 
rates of ammonia excretion. In the present study, it was shown that PEPCK 
reached fully adapted levels before the onset phase was complete. This 
suggests that PEPCK alone is not responsible for the slow adaptive 
increase in ammonia excretion and therefore may not be regulatory for 
the production of ammonia during this phase. On the other hand, the 
correlations between ammonia excretion and both maximal PDG activity and 
mitochondrial ammonia production in vitro are consistent with the mito-
chondrial response being responsible for the slow adaptation in ammonia 
excretion. However, at present, there is insufficient evidence to discern 
which mitochondrial step (i.e., glutamine transport, or conversion of 
glutamine to glutamate via PDG) if either, is rate-limiting. The hy-
pothesis suggesting that PDG amount is regulatory is weakened by the studies 
by Goldstein (29). The results of his studies show that an adaptive in-
crease in ammonia excretion, during the first 24 hours of acid challenge, 
can occur without an increase in PDG activity. However, it is certainly 
not justified to reject this hypothesis for the entire onset phase solely 
on the basis of a dissociation which occurs in only one part of this 
phase. Nor is it justified to accept the transport hypothesis as correct 
solely on the basis that no evidence has yet been produced against it. 
The transport hypothesis has not yet been subject to serious critical 
102 
study, probably because of the technical difficulties involved. 
During recovery, apparently only the extramitochondrial response is 
required to return ammonia production to normal. The dissociations 
between ammonia excretion and both maximal PDG activity and mitochondrial 
ammonia production in vitro suggest that the mitochondrial capacity is 
not rate-limiting for ammonia production during this phase. On the other 
hand, the apparent correlation between ammonia excretion and maximal PEPCK 
activity is consistent with this enzyme being involved in the regulation 
of amrnoniagenesis during recovery. One problem with this interpretation 
is that during starved recovery the maximal activity of PEPCK remains 
elevated, yet ammonia excretion for the same day has returned to normal. 
If ammonia excretion on this day actually reflects ammonia production 
(and it may not since extra ammonia may diffuse into the blood instead) 
then this dissociation may suggest that events other than those presently 
discussed, either mitochondrial or extramitochondrial are important. 
However, for the purpose of this model it appears that ammonia pro-
duction is regulated by a mitochondrial factor (possibly glutamine trans-
port or PDG amount) during the onset phase and by a cytoplasmic factor 
(possibly PEPCK amount) during the recovery phase. 
C. Possible Future Studies 
1. Early Recovery 
The results of the present work indicate that there is a difference 
in the time course for the return of ammonia excretion to normal in rats 
drinking 1.5% (w/v) NH4 Cl for 3 days compared to rats drinking 1.5% (w/v) 
NH4 Cl for 7 days. It would be of interest to see if PEPCK activity still 
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correlates with ammonia excretion during this 11earlyn recovery. 
2. Recovery 
Considering the results of the present study, a close look at the 
proposed regulatory events during recovery in rats after drinking 1.5% 
(w/v) NH4Cl for 7 days might be revealing. The present work indicates 
that both ammonia excretion and PEPCK activity return to normal with the 
same time course. However, neither of these events were measured at 
times less than 24 hr of recovery. Therefore, it would be important to 
know if PEPCK activity still correlates with ammonia excretion at re-
covery times less than 24 hr. It might also be worthwhile to see if ad-
ministration of NaHco3 , at the start of recovery, would reduce the time 
required for these events to return to normal, without dissociating them. 
If,during recovery, PEPCK amount is regulatory for ammonia production 
(by the proposed mechanism) then glutamate levels must increase sub-
stantially so as to inhibit the elevated levels of PDG and these elevated 
levels must persist until PDG has returned to normal. Measurement of 
cortical glutamate levels during recovery is therefore important. However, 
although it is not expected that cortical glutamate levels necessarily 
reflect mitochondrial glutamate levels, it is expected, because of the 
large increase in mitochondrial glutamate required to inhibit PDG, that 
the change in cortical [glutamate] would be even greater than is observed 
during onset. Another important aspect of the possible role of PEPCK 
in the regulation of ammonia production during recovery is the mechanism 
whereby PEPCK activity returns to normal. This would initially involve 
measuring the rates of synthesis and degradation of PEPCK during recovery. 
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The maximal activity of PDG does not fall significantly~ upon re-
covery~ for the length of time that it was followed (i.e., 2 days). It 
would be interesting to know how long it takes for PDG activity in vitro 
to return to normal. It would also be of interest to measure the rates of 
synthesis and degradation of PDG during onset, plateau and recovery. 
PDG activity and mitochondrial ammonia production need not necessarily 
return to normal with the same time course. If mitochondrial ammonia 
production returns to normal faster than the activity of PDG, then this 
would be consistent with the concept that adaptation of the transport 
process does occur_ 
The negative glutamine A-V differences observed during recovery 
suggest that glutamine synthesis is involved with reducing net ammonia 
production. It would therefore be of interest to look for changes in 
-glutamine synthetase activity (GS) and to ·study the effect of methionine 
sulfoximine (an inhibitor of GS (66)) on the activity of glutamine 
synthetase (in vivo) during the recovery phase. 
3. Rechallenge 
Dies and Lotspeich (25) found that there was no lag in the excretion 
of acid when rats were rechallenged with NH4 Cl immediately after recovery 
from a previous challenge. Presumably, this is because the capacity of 
the mitochondria to produce ammonia from glutamine is still elevated and 
that PEPCK can adapt rapidly. If this does prove to be the case, then it 
might be taken to suggest that adaptation of PEPCK during onset is not 
rate-limiting because it is capable or adapting rapidly, but that PEPCK 
is regulatory, after the mitochondrial capacity has adapted, during re-
covery and rechallenge. At the end of recovery, PDG is elevated while 
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PEPCK has returned to normal. If the elevated level of PDG is the result 
of a long half life, then it should be possible to use the high doses of 
actinomycin D, required to inhibit PEPCK adaptation (53), during 
rechallenge. This would help discern if an adaptive increase in PEPCK 
(or some other protein) is required for an adaptive increase in ammonia 
production during this phase. 
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